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Abstract
ABSTRACT
Autosomal dominant optic atrophy (ADOA) is a slowly progressive ocular disorder 
associated with retinal ganglion cell loss and optic atrophy, manifesting with a variable 
reduction in visual acuity, colour vision defects and visual field loss. Genetic studies lead 
to the identification of mutations in the OPA1 gene on chromosome 3q28-qter, which is 
the main ADOA-causing gene. OPA1 is an ubiquitously expressed, nuclear dynamin- 
related GTPase, targeted to the inner mitochondrial membrane, which plays a role in 
mitochondrial fusion and ultimately has a protective role against apoptosis.
In order to study the pathophysiology of ADOA, a new ENU-induced mutant mouse 
carrying a protein truncating nonsense mutation in Opal has been generated in our 
laboratory (B6;C3-OpalQ285STOP ). The heterozygous mutation leads to approximately 
50% reduction in Opal protein in mitochondria from retinal samples studied by Western 
blot. The homozygous mutation is embryonic lethal. The phenotype of heterozygous 
mutant mice is not associated with a severe neuro-degenerative process, in keeping with 
the variable and relatively mild phenotype observed in many patients with ADOA. Thus, 
visual phenotyping shows reduced visual function and electron microscopy reveals 
significant abnormalities in myelin bundles and increased autophagy with increasing age 
up to two years. Despite this, heterozygous adult mutants (up to 2 years of age) do not 
show age-dependent loss of retinal ganglion cell (RGC) bodies when studied on retinal 
sections stained with H&E and there is no visibly increased apoptosis in the retina (at 2 
years of age) on TUNEL staining. In retinas from mice of 4-5 months of age proteolysis 
of Opal is normal and no statistically significant reduction in the average mitochondrial 
membrane potential is observed in the retina and brain. Quantitative RT-PCR on retinal 
samples does not indicate any differences in the expression of the six genes involved in 
the mitochondrial structure in mutant versus wild type mice. However, the observation of 
mitochondrial network in Mitotracker stained mouse embryonic fibroblasts (MEFs) at 
E l3.5 demonstrates a higher incidence of fragmented mitochondria in MEFs taken from 
heterozygous mice, with a 15% increase in the number of opal +/- MEFs showing 
mitochondrial fragmentation (the average length of mitochondrial particles below 1 pm), 
when compared to Opal +/- MEFs. However, their growth and survival after oxidative 
stress (with H2O2 and blue light) was not significantly affected when compared to the 
wild type control in a MTT assay.
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In conclusion, in Opal +/- mice, a reduction in the mitochondrial level of Opal caused a 
mild defect in mitochondrial morphology without any significant decline in those cellular 
functions investigated.
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ABBREVIATIONS
A Adenine
ADOA Autosomal Dominant Optic Atrophy
ADO AD Autosomal Dominant Optic Atrophy and Deafness
ADP Adenosine diphosphate
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ATP Adenosine-5'-triphosphate
C Cytosine
CCCP Carbonyl cyanide m-chlorophenylhydrazone
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dUTP 2'-deoxyuridine 5'-triphosphate
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DMEM Dulbecco’s modified Eagle’s medium
D-PBS Dulbecco’s phosphate-buffered saline
Dpc Days post coitum
d-Rib 2-Deoxy-d-ribose
DTT Dithiothreitol
E Efficiency
EDTA Ethylenediaminetetraacetic acid
EM Embryonic stem cells
ENU N-ethyl-N-nitrosourea
EST Expressed sequence tag
FA Formaldehyde agarose
FBS Fetal bovine serum
G Guanine
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GED GTPase effector domain
Gin Glutamine
GO Gene Ontology
GOI Gene of interest
GTP Guanosine-5'-triphosphate
H&E Hematoxylin and eosin
HEPES 4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid
HET Heterozygote
H2O2 Hydrogen peroxide
HRM High resolution melt
HRP Horse Radish Peroxidase
IgG Immunoglobulin G
IMM Inner mitochondrial membrane
IMS Intermembrane space
INL Inner nuclear layer
IS Inner segments
kb Kilobase
LHON Leber Hereditary Optic Neuropathy
MEFs Mouse embryonic fibroblasts
MELAS Mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke­
like episodes
MERRF Myoclonic epilepsy associated with ragged-red fibers
MESA MOPS-EDTA-sodium acetate
MGI Mouse Genome Informatics
mOPA1 Mouse optic atrophy (gene)
MOPS 3-(N-Morpholino)propanesulfonic acid
mRNA Messenger ribonucleic acid
MS Mass spectrometry
mtDNA Mitochondrial deoxyribonucleic acid
MTT Thiazolyl Blue Tetrazolium Bromide
Mut Mutant
NADPH Nicotinamide adenine dinucleotide phosphate
NCBI National Center for Biotechnology Information
NMD Nonsense Mediated Decay
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Nnt nicotinamide nucleotide transhydrogenase
OCT Optical Coherence Tomography
OE Overexpression
OKN Optokinetic nystagmus
OMIM Online Mendelian Inheritance in Man
OMM Outer mitochondrial membrane
ONL Outer nuclear layer
O/N Optic nerve
OPL Outer plexiform layer
OXPHOS Oxidative phosphorylation
PAGE Polyacrylamide gel electrophoresis
PARL Presenilin-associated rhomboid-like
PEG Polyethylene glycol
PERG Pattern Electroretinogram
PBS Phosphate-buffered saline
PD Population doubling
PTC Premature termination codon
qRT-PCR Quantitative reverse transcription polymerase chain reaction
RFL Retinal fibre layer
RIPA Radio-Immunoprecipitation Assay
RGC Retinal ganglion cell
RNAi RNA interference
ROS Reactive oxygen species
RP Retinitis pigmentosa
RT-PCR Reverse transcription polymerase chain reaction
SD Standard deviation
SDS Sodium dodecyl sulphate
SEM Standard error of the mean
SIMH Stress-induced mitochondrial hyperfusion
SNP Single nucleotide polymorphism
SOD2 Superoxide dismutase 2
T Thymine
Tm Melting temperature
TBE Tris/Borate/EDT A
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TdT Terminal deoxynucleotidyl transferase
TE Tris/EDTA
TUNEL TdT-mediated dUTP nick end labeling
UV Ultraviolet
VIS Visible
WT Wild type
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Chapter 1 Introduction
1. INTRODUCTION
1.1 Inherited optic neuropathies
Inherited optic neuropathies form a genetically heterogeneous group of disorders with 
various modes of inheritance (autosomal dominant or recessive, X-linked recessive or 
mitochondrial) that are characterized by dysfunction of the optic nerve (Votruba et al., 
2004). As a result of genetic heterogeneity, there are considerable variations in the 
clinical presentation of optic atrophy diagnosed in these diseases. The general sign is a 
light, flat optic disc with well defined margins and a reduction in the numbers of the 
smaller diameter blood vessels supplying the disk. Nearly all of the inherited optic 
neuropathies eventually have symmetric, bilateral, central visual loss. In many of these 
disorders, the papillomacular nerve fibre bundle is affected, with resultant central or 
cecocentral scotomas. Optic nerve damage is usually permanent and, in many diseases, 
may be progressive (Newman, 2005).
The hereditary optic atrophies can be divided into two main groups. First, there are the 
primary optic atrophies, such as Leber hereditary optic neuropathy (LHON). In primary 
optic atrophy, the disease is linked to a specific genetic defect which results in 
degeneration of the retina and/or optic nerve fibres. Second, in secondary optic atrophy, 
the pathological changes affecting the optic disc are accompanied by many other 
symptoms in complex clinical syndromes, such as Wolfram and Behr’s and the damage to 
the optic nerve may be secondary to other pathological changes that take place in the 
body.
The two most common inherited optic neuropathies are autosomal dominant optic atrophy 
(ADOA, Kjers’ disease) and LHON. LHON (OMIM 535000) was described by Leber in 
1871 and is now recognized as the most frequently occurring mitochondrial disease. The 
condition is inherited through the female line by maternal transmission of mtDNA. 
LHON has usually a sudden onset of visual loss in both eyes asynchronously and appears 
at the age of 18-35 years. Both disorders are the result of mitochondrial dysfunction. 
Mutations in LHON affect the respiratory chain complexes, whereas the ADOA main 
nuclear-encoded gene OP AI codes for inner mitochondrial membrane protein critical for 
proper mitochondrial structural plasticity, mtDNA maintenance and oxidative 
phosphorylation. The fundamental pathology of both diseases is a degeneration of retinal
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ganglion cells (RGC) and atrophy of the optic nerve. However, other neurological defects 
and muscle abnormalities have also been reported in so-called “LHON plus” and “ADOA 
plus” syndromes (Jun et al., 1994; Amati-Bonneau et al., 2008). Both diseases are 
characterized by a variability in severity of visual dysfunction and an incomplete 
penetrance, which implies that additional genetic and/or environmental factors must 
modulate the phenotypic expression (Yu-Wai-Man et al., 2008). No current treatment is 
available for either disease.
1.1.1 Autosomal dominant optic atrophy: clinical features and 
histopathology
Autosomal dominant optic atrophy (ADOA) (OMIM 165500) is the most prevalent 
hereditary optic neuropathy with estimated disease prevalence ranging between 1:12,000 
in Denmark, and 1:50,000 worldwide. ADOA is a progressive disorder with onset in the 
first decade of life that often leads to legal blindness. Clinically it is characterized by a 
loss of visual acuity, development of centrocoecal scotoma, bilateral temporal atrophy of 
the optic nerve and colour vision disturbances (Votruba et al., 2003). The peripheral 
fields are usually full. The appearance of the optic nerve ranges from complete atrophy 
through temporal pallor to subtle pallor (Fig. 1.1).
Fig. 1.1 A left fundus photograph from a patient with ADOA, showing temporal pallor (from Votruba 
et al., 2003).
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ADOA has incomplete penetrance. It varies from family to family and mutation to 
mutation. It has been reported as high as 100% with the IVS12+lg>t mutation resulting in 
OPA1 exon 12 skipping (Thiselton et al., 2002) and as low as 43% with the 2708del 
(TTAG) mutation in OPA1 exon 27 (Toomes et al., 2001) and in some families 
asymptomatic carriers have been observed. Post-mortem histopathological studies of two 
patients identified a selective loss of RGCs, primarily in the macula and in the papillo- 
macular bundle of the optic nerve and loss of myelin (Johnston et al., 1979; Kjer et al., 
1983). Magnetic resonance imaging has also confirmed thinning of the optic nerve in 
ADOA patients (Votruba et al., 2000). Recent data from in vivo optical coherence 
tomography (OCT) have shown the thinning of the retinal layers, excluding outer layer 
with photoreceptors, in the macular area (Ito et al., 2007). On electrophysiology an absent 
or delayed pattern visual evoked potential has been observed showing that there is a 
conduction defect in the optic nerve. The pattern electroretinogram (PERG) shows 
reduced amplitude of the N95 waveform, suggesting RGC dysfunction (Beminger et al., 
1991; Holder et al., 1998). The colour vision defect is often reported as an acquired blue- 
yellow loss, or tritanopia (Eliott et al., 1993), but mostly a generalized non-specific 
dyschromatopsia has been diagnosed.
1.1.2 Different ADOA phenotypes
Recent genetic studies identified much broader spectrum of clinical phenotypes linked to 
mutations in the OPA1 gene. Apart from optic atrophy sensorineural deafness has been 
reported in so-called ADOAD disorder caused by missense mutation in exon 14, which 
leads to the amino acid change in the OPA1 GTPase domain (R445H) (Amati-Bonneau et 
al., 2003). In some cases of ADOAD chronic progressive external ophthalmoplegia 
(CPEO), ptosis and myopathy have been reported (Treft et al., 1984; Meire et al., 1985; 
Payne et al., 2004). Another multi-systemic disorder: “ADOA plus” has been described, 
which affects peripheral nerves, muscles and brain and is associated with missense 
mutations in the GTPase domain of OPA1 gene and mtDNA instability (Amati-Bonneau 
et al., 2008, Liguori et al., 2008). Recently one case of reversible ADOA, where 23-year- 
old man partially recovered from bilateral optic neuropathy, has been reported (Comille 
et al., 2008). The mutation in the alternative exon 5b was found to be responsible for this 
reverse effect.
21
Chapter 1 Introduction
This phenotypic variation in OPA1 diseases mirrors the effect of mutation on cellular 
function. In classic ADOA disease OP A 1 mutations affect mitochondrial morphology and 
ultrastructure, mitochondrial fusion and oxidative phosphorylation (Zanna et al., 2008). In 
patients with a more complex phenotype (ADOAD and “ADOA plus” syndromes) defects 
in mitochondrial morphology and oxidative phosphorylation have been found to be more 
pronounced (Fig. 1.2) (Amati-Bonneau et al., 2005; Chevrollier et al., 2008). Generally 
there are some reasons to believe that the pathomechanism depends on the type of OPA1 
mutation. Premature termination of translation that results in haploinsufficiency is mostly 
related to classic ADOA with affected RGC layer and optic nerve. Some mutations in 
GTPase domain may result in a dominant negative effect, in which dysfunctional OPA1 
protein still exists in the cell and does more harm than good. This effect could underlie 
more severe disease presentations.
Fig. 1.2 Mitochondrial network morphology. Fibroblasts from a control subject (left) and ADOAD 
patient carrying the R445H mutation (right). Cells were labeled with Mitotracker. In control fibroblasts 
mitochondria form interconnected network. In contrast more than 90% of the cells from patients have 
fragmented mitochondria (from Amati-Bonneau et al., 2005).
1.1.3 Genetic mapping studies in human and mouse
The predominant locus for ADOA was mapped to chromosome 3q28-29 (Eiberg et al., 
1994) and refined genetic mapping narrowed this region to 1.4 cM. (Jonasdottir et al., 
1997; Stoilova et al., 1997; Votruba et al., 1997). The nuclear gene, OPA1 that mapped 
within this candidate region was identified by two laboratories using either positional 
cloning and construction of a high-density PAC contig (Alexander et al., 2000) or by 
searching for a human Mspl/Mgmlp homologue in nucleotide databases and 
fluorescence in situ hybridization (Delettre et al., 2000).
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About 60% of ADOA cases are now linked to mutations in the OPA1 gene. Two further 
loci have been reported (OPA4 and OPA5), but the genes involved have not yet been 
identified (Kerrison et al., 1999; Barbet et al., 2005). Mouse mOpal was isolated as a 
mouse ortholog of the large G protein previously cloned from salmon brain. Amino acid 
sequence of the salmon clone was used as a probe to carry out a search of a mouse EST 
database followed by screening of a mouse brain cDNA library (Misaka et al., 2002). 
Comparison of mouse and human OPA1 sequences revealed 88% and 97% identity at the 
nucleotide and amino acid levels, respectively.
1.1.4 Structure of OPA1
1.1.4.1 Splice variants
The hOPA1 gene is composed of 31 exons that are distributed across ~ 100 kb of genomic 
DNA. The last exon is not coding, and exons 4, 4b, and 5b generate at least eight splicing 
isoforms (Delletre et al., 2001). The full open reading frame translates into a large 
predicted protein of 1015 amino acids. The isoform 1 without 4b and 5b exons produces a 
960 amino acid protein. A recent study, published whilst the work in this thesis was being 
undertaken, showed that in mice only two alternative exons 4b and 5b (without exon 4) 
are involved in the alternative splicing and form four mRNA isoforms (Akepati et al., 
2008). It is suggested that this complex posttranscriptional regulation of OPA1 enables 
cells to produce discrete protein isoforms with distinct functions. One study has shown 
that isoforms containing exon 4 have an evolutionary conserved function in mitochondrial 
fusion and maintenance of mitochondrial membrane potential, whereas isoforms with 
exons 4b and 5b are vertebrate specific and involved in cytochrome c release and control 
of apoptotic process (Olichon et al., 2007a).
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1.1.4.2 Transcript expression
Northern blot analyses of OPA1 transcripts have shown the ubiquitous presence of OPA1 
RNA in almost all human tissues examined (Fig. 1.3)
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489 b p /
Fig.1.3 RT-PCR analysis. Alternatively spliced exons 4, 4b and 5b produce multiple OPA1 transcripts 
in human tissues. Human thyroid (lane 1), retina (lane 2), kidney (lane 3), lung (lane 4), ovary (lane 5), 
skeletal muscle (lane 6), liver (lane7), heart (lane 8), colon (lane 9), fetal brain (lane 10), no RNA (lane 11) 
and leukocytes (lane 12) (from Delettre et al 2001).
Some splicing isoforms demonstrate different abundance in different human organs 
(Olichon et al., 2007a). The qRT-PCR analysis of different isoforms revealed that the 
Ex4-containing mRNAs are systematically abundant. In the liver, kidney and thymus, the 
presence of Ex5b predominated among all variants (e.g. splice variant 5) whereas in the 
brain, Ex4b was highly expressed (splice variant 7). Similarly to humans, expression of 
splice variants in mice showed a tissue-specific variability with the largest difference in 
the expression between neuronal tissue (brain) and other tissues studied (heart, kidney, 
liver) (Akepati et al., 2008). In brain tissue a splice variant 1 showed the highest 
abundance (Fig. 1.4). These results suggest that selective alternate splicing of OPA1 
mRNA may be important in the regulation of mitochondrial function in different tissues.
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Fig.1.4 Silver stained 5% PAGE gel after RT-PCR of mouse OPA1 transcript. Four splice variants
abundance was tissue-specific (from Akepati et al., 2008).
1.1.5 Mutation spectrum of OPA1
Screening of ADO A patients is still increasing the number of known pathogenic OPA1 
mutations. Currently (July 2009) there are 204 mutations registered in a specific eOPAl 
database (http:lbbma.univ.angers.fr/eOPAl/). Different OPA1 mutations have been 
reported in Caucasian, British, French, Belgian, German, Danish, Australian and Japanese 
families. The mutations are spread throughout the gene coding sequence, but 
the GTPase domain and the dynamin central region are more frequently affected (Fig. 1.5)
(Sp) generated by alternative splicing o f exons 4b and 5b were found in the mouse tissues and their relative
Mutations by domain
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I  GTPase Dom ain 
O thers 
6%  H  Basic Dom ain
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34%
Fig. 1.5 OPA1 mutation statistics (eOPAl database). (Ferre et al., 2005)
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At least 40% represent protein truncation which supports the view that dominant 
inheritance of the disease may result from haploinsufficiency of OPAl. Missense 
mutations have been found in the GTPase domain, which mostly affect conserved amino 
acids (Ferre et al., 2005; Olichon et al., 2007b; Thiselton et al., 2002; Toomes et al., 
2001; Votruba, 2004). OPAl mutations are mostly family specific but one common 
deletion mutation c.2826delT, which causes a frameshift mutation in exon 28, has been 
identified in 14 unrelated Danish families and was presumed to be an evidence for a 
founder effect (Thiselton et al., 2001). Splicing mutations potentially result in exon 
skipping. In the OPAl GTPase domain these mutations led to the lack of amino acids 
presumably critical for the GTPase activity. Some mutations may be semi-dominant, 
because one compound heterozygote patient has been reported to have more severe 
symptoms than the patient’s simple heterozygote parents and siblings (Pesch et al., 2001). 
In addition one 560-860 kb microdeletion on chromosome 3q28 that results in the 
complete loss of one copy of the OPAl gene was reported (Marchbank et al., 2002) and 
recently genomic aberrations at the OPAl gene locus have been shown in ADO A patients 
(Fuhrmann et al., 2009).
1.2 OPAl protein
1.2.1 The Dynamin-related GTPase protein family
4b 11 13 16 19 23 26 28
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Fig. 1.6 Structure of human O pal. Boxes and numbers depicting exons (from Eopal database).
OPAl is a dynamin-related GTPase required for mitochondrial fusion and regulation of 
apoptosis (UniProtKB/Swiss-Prot 060313). At the N-terminal OPAl contains a highly 
basic domain with a mitochondrial leader sequence, which imports OPAl into 
mitochondria (Fig. 1.6). After a mitochondrial import sequence there is a putative 
transmembrane domain which may anchor the protein into the mitochondrial membrane. 
There are two coiled coil domains, which may be involved in the formation of 
homodimers or polymers (Olichon et al., 2007a). The first coiled coil is located within
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exons 5b to 7. The other predicted coiled coil is located at the extreme C-terminal and is 
thought to be GTPase effector domain (GED or assembly domain involved in the 
oligomerization and activation of dynamins). Crucial for OPAl fusion activity is a 
GTPase domain. This domain is highly conserved between dynamin-related proteins. 
Mutations in this domain result in mitochondrial fragmentation in fibroblasts from ADOA 
patients (Olichon et al., 2007b). Next to GTPase there is a dynamin central domain of 
unknown function.
There is still much to discover about Opal self-assembly, detailed interactions with other 
molecules and the mechanism of GTP binding/hydrolysis. So far the evidence presented 
suggests that Opal physically interacts with different respiratory complexes subunits 
(Zanna et al., 2008).
Dynamins play an important role in membrane-associated cellular processes. They are 
large proteins characterized by their common structure and by conserved sequences in the 
GTP-binding domain. As mentioned above for Opal, the GTPase domain is followed by 
a central domain and an assembly domain which typically has a propensity to form coiled 
coil. It is suggested that a common property of all these proteins is to self-assemble into 
higher ordered oligomers on specific templates (i.e. membranes) and to undergo a 
conformational change upon GTP binding or hydrolysis. The prototype for this family is 
dynamin, a protein involved in endocytosis (Danino and Hinshaw, 2001; van der Bliek, 
1999). A series of binding interactions between its three domains have been proposed and 
suggested how dynamin might form a spiral and then constrict a membrane. (Smirnova et 
al., 1999).
A well established function of dynamin-related proteins is regulation of mitochondrial 
morphology and distribution (Rube and van der Bliek, 2004). Genetic studies in yeast, 
Drosophila melanogaster and Caenorhabditis elegans have identified several of these 
highly conserved proteins and their homologues have been found in humans and mice. In 
yeast mutations in Dnml, and a homologous protein from C. elegans, called Drpl, block 
mitochondrial division (Bleazard et al., 1999; Otsuga et al., 1998). While overexpression 
of Drp-1 triggers mitochondrial fission in C. elegans, knockdown of Drp-1 by RNAi 
silencing has a converse effect and blocks mitochondrial outer-membrane scission. 
Immuno-electron microscopy and immunofluorescence show that Dnml and Drpl co- 
localize with constrictions in mitochondria. A human dynamin related protein Drpl is
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most closely related to C. elegans Drpl (62% amino acid identity) and is postulated to be 
responsible for proper distribution of mitochondria throughout the cell and mitochondrial 
division (Smirnova et al., 2001; Smirnova et al., 1998) Knock-down of Drpl (Drp-RNAi) 
causes excessively elongated and interconnected mitochondria that often collapse into 
perinuclear aggregates (Chen et al., 2003).
Another dynamin-like protein discovered in Saccharomyces cerevisiae: Mgmlp is the 
OPAl orthologue and like OPAl has a mitochondrial leader sequence in its highly basic 
amino-terminal domain. Deletion of Mgmlp in yeast leads to extensive mitochondrial 
fragmentation, loss of mitochondrial DNA, deficits in respiration and abnormal cristae 
structure (Jones and Fangman, 1992; Sesaki et al., 2006; Wong et al., 2000).
1.2.2 OPAl isoforms
In a Western blot analysis, human or mouse OPAl is detected as six distinct bands 
between 100 and 80 kDa (Fig. 1.7). In mice the identity of all the six bands was confirmed 
by electron spray ionization tandem MS/MS (mass spectroscopy) (Akepati et al., 2008). 
These bands (two long L-isoforms and three short S-isoforms) are the products of the 
translation of distinct mRNA isoforms and posttranslational proteolytic processing.
Mouse
Band-1; Isoform 7 
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Fig. 1.7 Six different protein isoforms are translated from four OPAl splice variants and undergo 
proteolytic processing. Western blot analysis o f mouse mitochondrial lysates from brain, liver, heart and 
kidney, total protein lysates from mouse astrocytes, retina and mouse embryonic fibroblasts (MEF); total 
protein lysates from human leukocytes, COS-1 cells and mitochondrial lysates from HeLa cells as detected 
by a-OPAl monoclonal antibody show six different protein isoforms (from Akepati et al., 2008).
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Both isoforms exist in yeast Mgml (OPAl ortholog) and the small isoform (s-Mgml) is 
produced after cleavage of the mature form by the mitochondrial rhomboid protease 
Pcpl/Rbdl/Mdm37/Ugo2- a homolog of serine protease Rhomboid (Herlan et al., 2003). 
The expression of both isoforms in yeast is essential for the maintenance of mitochondrial 
morphology and mtDNA. In PARL knockout mouse (PARL is the homolog of yeast 
Rbdl in mammals and the so-called “presenilin- associated rhomboid-like”) the reduction 
of a soluble, intermembrane space (IMS) form of OPAl in Pari'/_ cells has been observed 
indicating the importance of rhomboid protease in mouse OPAl isoforms processing 
(Cipolat et al., 2006).
1.2.3 Opal protein localized to mitochondrial membrane
Mitochondria are double membrane organelles composed of outer (OMM) and inner 
(IMM) membranes. The large surface area of the inner membrane is shaped into 
numerous invaginations, or cristae (Fig. 1.8). Cristae is highly specialized and contains the 
electron transport chain responsible for producing energy in the process of oxidative 
phosphorylation and ATP synthesis (Sesaki et al., 2006). The formation of cristae is 
supposed to facilitate ATP production by enabling more electron transport chain 
complexes to be packed into the mitochondrion. Crista are highly flexible, and undergo 
morphological changes in response to alteration of the metabolic state and/or matrix 
volume.
Fig. 1.8 The tomogram of the mitochondrion (from http://www.sci.sdsu.edu/TFrev/MitoMovie.htm).
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OPAl localization to mitochondria has been experimentally confirmed by co-localization 
with Hsp60 in HeLa cells (Olichon et al., 2007a) and reporter gene analysis: fusion of the 
N-terminal 60 or 90 amino acids of mOPAl with green fluorescent protein results in its 
mitochondrial targeting. Also subcellular distribution of mOPAl overexpressed in COS-7 
cells largely overlaps that of endogenous cytochrome c, a well known mitochondrial 
marker. Subcellular localization of mOPAl has also been investigated in primary culture 
of dissociated rat cerebellar cells, where it shows labelling, distributed in a vesicular 
pattern in the somas of MAP-2-positive neurons and a weaker signal in the dendrites 
(Misaka et al., 2002).
OPAl is closely associated with the inner membrane although it has been reported that 
different isoforms of OPAl produced by the alternative splicing are sublocalized to the 
inner and outer mitochondrial membranes of HeLa cells (Olichon et al., 2002; Satoh et 
al., 2003). In proteolysis experiments OPAl is digested together with the IMS marker 
Tim 13. Analysis by electron microscopy using antibodies to OPAl has shown most gold 
grains within mitochondria close to cristae and no labelling has occurred on the external 
border delimited by the OM. Labelling of the cristae by anti-OPA1 has been confirmed 
by the similar pattern of gold grain distribution obtained using antibodies to UCP, a 
cristae marker (Olichon et al., 2002).
OPAl L- isoforms are anchored to the inner membrane and processed to soluble S- 
isoforms (Ishihara et al., 2006) (Fig. 1.9). It appears that OPAl specific processing and 
sublocalization of its isoforms in mitochondrial membrane compartments enable OPAl to 
regulate cristae structure and thus perform its anti-apoptotic activity. It has been 
postulated that some OPAl molecules localize to IMS and cristae matrix and contribute 
to the maintenance of cristae integrity. Other molecules, and currently it is believed that it 
could be an isoform containing exon 5b (Olichon et al., 2007a), form the cristae junctions 
which are the gates through which cytochrome c is released during apoptosis. By keeping 
these junctions tight, OPAl could prevent (or delay) apoptotic events (see also 1.26).
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Fig.1.9 Schematic representation of OPAl roles in structuring cristae, cristae junction and 
the interaction between outer and inner mitochondrial membranes.
Dots in pink represent OPAl L-isoforms anchored to the membrane, dots in green represent OPAl 
S-isoforms not interacting with the membrane, both being required for cristae structure and OMM to IMM 
bridging. Dots in red represent OPAl isoforms forming the cristae junction. Cytochrome c, depicted as 
green stars, is mostly segregated in the cristae volume (from Lenaers et al., 2009); IMS- intermembrane 
space.
1.2.4 Opal responsible for mitochondrial fusion
Mitochondria are known to be motile and to undergo frequent divisions or to fuse with 
other mitochondria (Karbowski and Youle, 2003). Sometimes mitochondria exist as a 
single elaborate network and at other times they become fragmented, both events are 
physiological and in normal cells proceed smoothly and under the control of cellular 
mechanisms (Fig. 1.10).
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Fig.1.10 Network-like organization of mitochondria in cultured cells.
HeLa cells were stained with anti-cytochrome c antibodies and imaged using confocal microscopy (from 
Benard and Karbowski, 2009).
Mitochondrial fission is required in dividing cells to ensure inheritance of mitochondria 
by daughter cells but also occurs in postmitotic cells that are not able to divide, such as 
neurons. It is an important event during differentiation, in response to new energy 
demands and as a result of toxin exposure. Mitochondrial fission is balanced with 
mitochondrial fusion. The best known function of mitochondrial fusion is to maintain 
mitochondrial tubular morphology which exerts a protective effect on mitochondrial and 
cellular function. For example it can protect p-cells against nutrient-induced apoptosis 
(Molina et al., 2009). It can facilitate transfer of the mitochondrial membrane potential 
from oxygen-rich to oxygen-poor cellular regions. It can allow for an interaction of 
mtDNA gene products and prevent the stochastic depletion of materials, such as 
metabolic substrates and mtDNA. Cell hybrids between parental cells containing mutant 
mtDNA molecules result in restoration of respiratory activity indicating that 
complementation of mtDNA products can occur in fused mitochondria. In Drosophila 
mitochondrial fusion is a necessary event during development, and blocking 
mitochondrial fusion by mutation of the fuzzy onion (Fzo) gene (homologue of 
mammalian MFN1 and MFN2) results in male sterility (Hales and Fuller, 1997). Fusion- 
defective cells have dramatically reduced growth rates, reduced respiration, an increase in 
reactive oxygen species (ROS) and a highly heterogeneous mitochondrial population
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prone to loss of Av|/ (mitochondrial membrane potential) and the mtDNA. Such cellular 
defects have been observed in OPAl-RNAi or Mfn-null (lack both of Mfnl and Mfn2-) 
mammalian cells and were corrected upon restoration of mitochondrial fusion (Chen et 
al., 2003).
Different proteins control mitochondrial fusion and fission. Fusion is a multi-step process 
requiring the coordinated action of both the outer and inner membranes, ultimately 
resulting in mixing of matrix contents. Mitofusins (Mfnl and Mfn2) are the proteins that 
act early and are essential for outer membrane fusion, whereas OPAl is required for only 
inner membrane fusion (Song et al., 2009). This process requires the combined actions of 
S- and L-OPA1 isoforms (Song et al., 2007). Interesting results were obtained from 
overexpression of OPAl protein (OPA1-OE) or its individual isoforms. Overexpression 
of wild type or mutant forms of Opal protein, in particular with Gln297 mutation affecting 
GTPase activity, caused mitochondria to fragment and accumulate to various extents in 
the cells near the nucleus (Misaka et al., 2002). However studies using PEG fusion assays 
showed that while OPAl-RNAi cells are devoid of any mitochondrial fusion even after 
24hr. OPA1-OE cells were still able to fuse their mitochondria as efficiently as wild-type 
cells and the mitochondrial fragmentation observed in these cells was not due to the lack 
of fusion. Interestingly, mitochondrial fragmentation due to OPAl overexpression was 
blocked when the fission molecule Drpl was down-regulated by RNAi showing the 
balance between fusion and fission action in cells (Chen et al., 2003). The essential role 
of OPAl in fusion was also shown in yeast cells where a strong loss of OPAl orthologue- 
Mgml function caused mitochondria to be incapable of fusion, even when the 
mitochondrial fragmentation phenotype was suppressed by mutations in the yeast 
mitochondrial division protein Dnmlp (Sesaki et al., 2006). Moreover the Opalp role in 
fusion depends on another mitochondria shaping protein: Mitofusinl (Mfnl). In cells 
deficient in Mfnl, Opal could not promote mitochondrial fusion (Cipolat et al., 2004). 
Important results in relation to optic atrophy came from knockdown of Opal in retinal 
and cerebellar ganglion cells. Opal knockdown resulted in mitochondrial network 
aggregation in both cell cultures but occurred at a higher rate in retinal than cerebellar 
ganglion cells (Kamei et al., 2005).
33
Chapter 1 Introduction
1.2.5 OPAl processing and mitochondrial membrane potential
Mitochondrial membrane potential is the electrochemical gradient that exists across the 
mitochondrial inner membrane and is maintained by the electron transport chain (Detmer 
et al., 2007). Mitochondrial membrane potential is an integral part of the respiratory 
process and reduced mitochondrial membrane potential may indicate dysfunction in 
energy production. Recent observations have shown that dissipation of mitochondrial 
membrane potential induces OPAl proteolytic processing (Ishihara et al., 2006). Many 
apoptotic stimuli were also shown to exert this effect and this process has been linked to 
the decrease in the ATP level in mitochondria (Baricault et al., 2007).
OPAl processing leading to accumulation of S-OPA1 isoforms was found in patients 
suffering from mitochondrial diseases marked by an impaired respiration (Duvezin- 
Caubet at al., 2006) (Fig. 1.11). Moreover, it was shown on mouse embryonic fibroblasts 
derived from mice with homozygous knock-in of a variant of mtDNA polymerase y. The 
reduction of larger Opal isoforms with the ultimate increase in the levels of the shorter 
forms was associated with severe mitochondrial dysfunction and was also accompanied 
by extensive fragmentation of the mitochondrial network (Fig. 1.12).
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F ig .l.ll  Patterns of OPAl isoforms are altered in tissue samples exemplary of mitochondrial 
dysfunction. Homogenates from skeletal muscle biopsies from control individuals (A-D) and from patients 
suffering from respiratory disorders analyzed by western blotting for O PA l. The smallest form o f OPAl 
detected is indicated by an arrow (from Duvezin-Caubet et al., 2006).
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Control Mutator Control Mutator
Fig. 1.12 Mutator mouse embryonic fibroblasts show fragmentation of mitochondria. Immortalized 
mouse embryonic fibroblasts from two control mice and two mutator mice were cultured, stained with 
MitoTracker (red), fixed, and either immunostained against cytochrome c (green) or stained with DAPI 
(blue). Merged confocal fluorescence images are shown. Top, overview (scale bar 20 pm); bottom, 
indicated box, (scale bar 10 pm). Mitochondrial (from Duvezin-Caubet et al., 2006).
Degradation of OPAl stimulated by dissipation of the mitochondrial membrane potential, 
for example with CCCP (carbonyl cyanide w-chlorophenylhydrazone), requires the action 
of specific mitochondrial proteases (Guillery et al., 2008). In the inner membrane 
compartment there are AAA proteases: ATP-dependent proteolytic complexes, which 
expose their catalytic sites at opposite membrane surfaces: toward mitochondrial matrix 
and intermembrane space (IMS) (Arnold and Langer, 2002). Studies showed the 
involvement of m-AAA proteases in OPAl processing (Ishihara et al., 2006; Duvezin- 
Caubet et al., 2007). However, further experiments are required to point at the different 
activity of specific proteases in OPAl processing in physiological (posttranslational 
modification of the protein) and pro-apoptotic conditions.
Mouse embryonic fibroblasts lacking Opal have defects in mitochondrial membrane 
potential and respiratory capacity (Chen et al., 2003). A decrease in the mitochondrial 
membrane potential was observed in fibroblasts from ADOAD patients harbouring the 
R445H mutation and suffering from optic atrophy and deafness (Amati-Bonneau et al., 
2005). In addition, OPAl mutations in ADOA fibroblasts have been shown to impair 
ATP synthesis driven by complex I under forced oxidative metabolism (fibroblast were
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grown in galactose medium) (Zanna et al., 2008). However in another study, energetic 
efficiency, including mitochondrial membrane potential, was reported to be normal, 
despite prominent defects in mitochondrial morphology and distribution observed in 
fibroblasts and myotubes from ADOA patients (Spinazzi et al., 2008).
When defects in mitochondria accumulate mitochondria lose membrane potential, OPAl 
and fusion capacity and are targeted to autophagy (Twig et al., 2008). Autophagic 
degradation separates defective mitochondria from the pool of healthy mitochondria, 
which continue fusion & fission cycle (Fig. 1.13).
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Fig.1.13 A model of the mitochondrion’s life cycle that integrates mitochondrial dynamics and 
turnover. The mitochondrion cyclically shifts between a post fusion state (network) and a post fission 
state (solitary). Fusion is brief and triggers fission. Following a fission event, the daughter mitochondrion 
may either maintain intact membrane potential (red line) or depolarize (green line). If it depolarizes, it is 
unlikely to proceed to a subsequent fusion, unless it re-polarizes. After being depolarized and solitary for a 
few hours, the mitochondrion is removed by autophagy (from Twig et al., 2008).
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1.2.6 Opal involvement in apoptosis and cellular response to stress
During apoptosis mitochondria undergo changes in mitochondrial architecture and 
permeability, which facilitate the apoptotic process (Green and Kroemer, 2004; Youle 
and Karbowski, 2005). Apoptosis is a complex process and numerous studies have 
focused on establishing the links between various events taking place during apoptosis. 
The release of cytochrome c and other pro-apoptotic factors, e.g. AIF, from mitochondria 
seems to be the key event. Several findings have recently pointed at the significant role of 
OPAl in this process. It was shown that downregulation of OPAl in HeLa cells by small 
interfering siRNA resulted in mitochondrial fragmentation, dissipation of the 
mitochondrial membrane potential and drastic disorganization of the cristae, which was 
followed by cytochrome c release and apoptosis (Olichon et al., 2003; Griparic et al., 
2004; Amoult et al., 2005). At an early time point after transfection mitochondria were 
not yet fragmented, but marked morphological changes such as swelling and stretching 
were observed. Similar changes were also observed before in cells that were at the early 
stage of apoptosis (Frank et al., 2001). Mitochondria also formed localized constrictions 
(“the beads on string”), which were assumed to lead to mitochondrial fragmentation. Of 
most importance is that due to OPAl depletion prominent remodelling of the 
mitochondrial cristae was revealed by electron microscopy (Fig. 1.14).
control siRNA OPAl siRNA
Fig. 1.14 Mitochondrial ultrastucture. HeLa cells were transfected sequentially 3 times with control or 
OPAl siRNA and mitochondrial ultrastructure was investigated by transmission electron microscopy. Bars 
represent 500nm (from Amoult et al., 2005).
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In one study the most striking abnormalities in the morphology of the cristae were 
observed in cells at the stage when the level of OPAl protein was reduced by 8 6 % 
(Griparic et al., 2004). OPAl controls the shape of mitochondrial cristae by keeping their 
junctions tight, which is correlated with OPAl oligomerization and prevents from 
mobilization of cytochrome c from the cristae stores during apoptosis. The proapoptotic 
BCL-2 family member BID, which widens cristae junctions, also disrupts Opal 
oligomers (Frezza et al., 2006). In one experiment the delay in release of cytochrome c 
induced by H2O2 was achieved by the expression of OPAl, whereas the expression of 
OPAl mutant: (OPA1k301a with the mutation of conserved amino acid in the GTPase 
domain) failed to protect from H2O2 (Fig. 1.15).
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Fig. 1.15 OPAl Delays Release of Cytochrome c during apoptosis.
A) Representative images o f subcellular cytochrome c distribution. WT MEFs were cotransfected with 
mtRFP (red), and the indicated plasmids were left untreated or treated for 30 min with ImM H20 2 fixed and 
immunostained for cytochrome c (green). Bar, 15pm. B) Localization index of cytochrome c. Experiments 
were performed as in A but cells were fixed at the indicated times (from Frezza et al., 2006)
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OPAl mutations in ADO A can lead to the increased vulnerability to apoptosis, as 
demonstrated in fibroblasts taken from ADOA patients and treated with staurosporine 
(Olichon et al., 2007b).
Interestingly, new mechanism that requires OPAl activity and represents an adaptive 
pro-survival response against stress has been recently described. In cells exposed to 
selective stressful stimuli, e.g. UV light mitochondria hyperfuse and form a highly 
interconnected network. This stress-induced mitochondrial hyperfusion (SIMH) was 
shown to be dependent on L-OPA1 (but not S-OPA1) (Tondera et al., 2009).
1.3 Mitochondrial trafficking in neurons
Neurons rely heavily on mitochondrial function for their energy supply and specialized 
neuronal functions, including membrane ionic pumps, channel activity and synaptic 
transmission (Hollenbeck, 2005). Proper distribution and networking of mitochondria in 
axons and at synapses is critical for synaptic plasticity and axonal outgrowth since it has 
been shown that Opal and Drpl are important for development and/or maintenance of 
spines and synapses in hippocampal neuron culture (Li et al., 2004). In the optic nerve 
mitochondria show a specific distribution pattern: they are abundant in the unmyelinated 
initial portion of the RGC axons before the lamina cribrosa, whereas the postlaminar 
optic nerve is myelinated and has less mitochondria (Carelli et al., 2007; see also 1.3.1). 
It is possible that this specific mitochondrial arrangement is affected in ADOA disease 
and contributes to the degenerative process of RGCs (Spinazzi et al., 2008). Yu Wai Man 
et al., (2005) postulated that disruption of the mitochondrial gradient could cause 
profound ATP depletion and increased production of free radicals, which would disturb 
conduction through the optic nerve head and ultimately RGC death.
Recently in vivo imaging of the mouse retina showed that mitochondria in RGC and optic 
nerve are short, punctuated and often form clusters, while non-neuronal cells exhibit 
longer, highly interconnected mitochondrial network (Uo et al., 2009). This difference 
may be taken into account when addressing the issue of particular vulnerability of RGC 
in ADOA disease.
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1.3.1 Optic nerve physiology
All 1.2 million fibers of the optic nerve derive from the RGC of the inner retina (Carelli 
et al., 2004). Each RGC axon travels into the nerve fibre layer (NFL) and then toward the 
optic nerve head. These unmyelinated NFL axons form varicosities rich in mitochondria 
and desmosome- and hemidesmosomelike junctions with other axons or glial cells. At the 
optic nerve head axons turn posteriorly and pierce the many collagen plates that form the 
lamina cribrosa. Posterior to the lamina cribrosa, the axons become myelinated by 
oligodendroglia and build the optic nerve where a sharp decrease in mitochondrial 
numbers is observed (as shown by decreased COX staining (Fig. 1.16). This reflects the 
differences in functional requirements of unmyelinated versus myelinated section of the 
nerve. Unmyelinated RGC axons are bioenergetically weak, have much slower 
conduction velocities and require more energy to restore the electrical potential, as 
compared to the posterior myelinated portion of these same axons which use saltatory 
conduction.
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Fig. 1.16 RGC system: diagrammatic view of pattern for staining of COX.
Cytochrome c oxidase (COX) accumulates at the sites o f greatest oxidative phosphorylation (OXPHOS). 
Intense COX staining characterizes the NFL and the prelaminar RGC axons. This staining suddenly 
decreases posteriorly in concert with the appearance o f myelin posterior to the lamina. On the left side is a 
sagittal view o f the human eye. The boxed part is enlarged. There is a drastic decrease in mitochondrial
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numbers within the retrolaminar portion (COX-). Mitochondria, in this part o f the RGC axon, are mostly 
located under the unmyelinated nodes o f Ranvier. On the right side is illustrated a histological sagittal 
section o f a normal human eye showing a parallel transition from the retina to the optic nerve head, the 
lamina cribrosa and a portion o f the myelinated retrolaminar optic nerve. The ocular tissue was stained by a 
method using immunoperoxidase for myelin basic protein, (from Carelli et al 2004).
1.4 Animal models of ADOA
1.4.1 Mouse models- natural mutants, chemical mutagenesis and technology 
of knockout and transgenic animals
Mouse models provide a valuable tool for investigating the genetic basis and the 
pathophysiology of human diseases, and to evaluate therapeutic treatments. At present, 
197 genes are known to be involved in the formation of retinal diseases in humans 
(RetNet, http://www.sph.uth.tmc.edu/Retnet), but mouse models are available for only a 
few of them (Dalke and Graw, 2005).
One of the first mouse mutants described in the field of vision research was the rodless 
mouse (r); Keeler, 1924), which carries a nonsense mutation in the Pde6 b gene coding for 
the p-subunit of phosphodiesterase. The gene mutation was later discovered in the retinal 
degeneration mouse (actual gene symbol Pde6 b^7, formerly referred to as rdl or rd 
(Pittler and Baehr, 1991). This mouse mutant has been the most extensively studied 
model for human autosomal recessive retinitis pigmentosa (RP). Several common mouse 
inbred strains, like C3H, SWR and FVB, are homozygous carriers of the Pde6brdl allele 
(Jax Notes, 2002, http://iaxmice.iax.org/iaxnotes/archive/485.pdf.)
The most common and convenient way to make transgenic mice is pronuclear injection of 
fertilized eggs which results in a random insertion of a DNA sequence into the genome. 
Knockout mice are produced by gene targeting and gene trapping in embryonic stem 
(EM) cells, which are vector-based techniques and ENU mutagenesis. In the year 2004 
published knockouts exist for about 10% of mouse genes (Austin et al., 2004).
A big collection of the spontaneous mouse mutant lines is maintained and characterized 
in the Jackson Laboratory. The limitation of this approach is the low frequency at which 
spontaneous mouse mutants occur. One of the spontaneous mutants is (nr) nervous mouse
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in which retinal degeneration combined with the loss of cerebellar Purkinje cells is 
observed (De Jager et al., 1998).
N-ethyl-N-nitrosurea (ENU) is currently the most powerful mutagen for the generation of 
large numbers of new mutants including allelic series of single genes.
ENU targets premeiotic spermatogonial stem cells inducing discrete lesions, specifically 
point mutations, through alkylation of nucleic acids. The most common mutations 
induced by ENU are A/T —> T/A transversions and A/T —► G/C transitions.
By contrast other efficient germline chemicals such as chlorambucil or radiation usually 
cause large deletions or inversions that often involve more than one gene. ENU 
mutagenesis has been carried out for systematic phenotype-driven studies of mammalian 
gene function which can model human disease but can also be used for a gene-driven 
identification of new mutations. Genome-wide screens for both recessive and dominant 
mutations can be carried out and phenotypes not evident in recessive screens, including 
dominant, gain-of-fimction mutations, dominant-negative mutations, and mutations 
arising from haploinsuffiency can be revealed (Hatten and Heintz, 2005; Justice et al., 
1999).
1.4.2 B6;C3-OpalQ2S5STOF mouse model of ADOA
In order to study the mechanism of ADOA disease, a new mouse targeted Opal mutant 
has been generated in our laboratory by ENU mutagenesis (Davies et al., 2007). 10,000 
DNA samples from ENU-treated C3H male strain mice (Ingenium) were screened. Exons 
1, 8 , 9, 10, 12, 28 of OPAl were amplified by PCR following heteroduplex analysis by 
temperature gradient capillary electrophoresis (TGCE: SpectuMedix). 5 SNPs were found 
in OPAl. One nonsense mutation 1051C—>T in OPAl was selected for IVF (in vitro 
fertilisation), as it appeared to be highly likely to represent a functional allele. This 
mutation inserts a STOP signal instead of glutamine amino acid (Q285X) in exon 8  and 
causes premature protein truncation.
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Western blot for Opal on different mutant mouse tissues showed the reduction of Opal 
(Fig. 1.17).
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Fig. 1.17 Western blot showing expression of the OPAl protein in a panel of tissues taken from
Opal+A and Opal++ mouse. Protein extracts from retina, brain, heart and liver, kidney, skeletal 
muscle, spleen and RGC-5 cells. Equal loading was assessed by (3-actin expression, 
and RGC-5 cells were used as an internal control for Opal (from Davies et al. 2007).
Homozygous mutant mice die at the embryonic stage, while heterozygous mutant mice 
develop relatively mild symptoms of optic neuropathy without any gross abnormalities 
affecting other organs. However, in a SHIRPA neurological assessment, which allows 
observational assessment of 37 different general health and neurological measures, 
reduced locomotor activity in the 6 month old Opal +/- mice was found, which may 
reflect early changes in neurological function. Visual function in heterozygous mice was 
tested with the optokinetic drum (OKN) and the circadian running wheel. Both tests 
showed the functional reduction in visual function in 12 month old Opal +/- mice. In 
contrast to WT mice, Opal+/- mice continued their running wheel activity during the 
presentation of the light at night, indicating that they had not seen or detected the light. 
On OKN drum mutant mice could track all gratings, as WT mice, however did it less 
often than littermate controls (Fig. 1.18).
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Fig. 1.18 Performance on the optokinetic visual screening test.
Mean time spent tracking a moving 2° 4° and 8° grating on the optokinetic drum at 12 months of age. The 
Opal+/- mice track all three gratings less often compared to littermate controls (from Davies et al., 2007).
In 3 month old heterozygous mice an apparent alteration in mitochondrial morphology, 
with an increase in mitochondrial fragmentation was demonstrated by fluorescent 
microscopy in muscle explants. Retinal morphology appeared normal in the 6 -month-old 
Opal+/~ mice and there was no RGC loss on H&E stained retinal sections at this age 
(Fig. 1.19).
B
Opal+/-
Fig. 1.19 Analysis of the RGC layer of Opal +/- mutant compared with O pal +/+ control.
(A) Representative H&E retinal section from an O pal+/- (A) and Opal +/+ mouse (B). The Opal +/- mice 
display equivalent RGC counts compared with littermate controls. O/N, optic nerve; OS, outer segments; 
IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; RGC, 
retinal ganglion cell layer. Bar 100pm.
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No significant abnormalities were also observed in the optic nerve sections from 6 -month- 
old opal+ /-mice on electron microscopy. However, by 9 months of age and at 18 and 24 
months abnormal axons and myelination were seen (Fig. 1.20).
Fig.1.20 Electron micrographs of optic nerve axons from 24-month-old mice.
Axon abnormalities were classified as (A) watery degeneration {asterisk), (B) dark degeneration {asterisk), 
(C) myelin clumping {arrow), and (D) demyelination. Areas o f normal optic nerve from 24-month-old (E) 
and 6-month-old (F) mice (from White et al., 2009).
Opal +/- mice demonstrated age- related axon loss from the optic nerve. There was also 
an increase in the number of autophagosomes in the RGC layer in 24 month old 
heterozygous mutants, which suggested the increase in the number of dysfunctional, 
depolarized mitochondria that were targeted to degradation (White et al., 2009) 
(Fig. 1.21).
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Fig.1.21 Electron micrograph of early- and late-stage autophagy in retinal ganglion cell layer from a 
24-month-old mouse. In the earlier stage, the doublemembrane bound structure (arrow) is fusing with a 
lysosome (arrowhead). At the later stage (asterisk), fusion with the lysosome has taken place, and the 
structure is undergoing proteolysis (from White et al., 2009).
It was also found that some mitochondria in the optic nerves of 24-month-old Opal +/- 
mice had structural abnormalities and vesiculation of the inner membranes. In addition, 
an increase in the number of opaque mitochondria, which may represent an increase in 
the density of cristae in order to fulfill the energy requirements of the axon, were seen by 
electron microscopy by 6  months of age. However, 11 month old Opal +/- mice did not 
show cytochrome c oxidase deficiency or accumulate secondary mtDNA defects in their 
RGC layer (Yu Wai Man et al., 2009).
In conclusion OPAl heterozygous mutant mice show slow and age-related degeneration 
of the optic nerve associated with mitochondrial morphological abnormalities and 
increased autophagy.
1.4.3 Other models of ADOA
Another mouse model has been recently published (Alavi et al., 2007). The mutant mouse 
has a splicing mutation in OPAl, which induces skipping of exon 10 during transcript 
processing and leads to the deletion of 27 amino acids in the GTPase domain. Like 
B6;C3-0/?tf7Q285STOP, homozygous mouse mutants are lethal at the early embryonic stage,
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whereas heterozygous mutant mice showed an age-dependent degeneration of the optic 
nerve. Electron microscopy micrographs o f axial section through the optic nerve showed 
significant reduction of axons and swelling of remaining axons. Mitochondria in these 
axons had disorganized cristae. In the retina progressive loss of RGCs was observed so 
that at the age of 13 months mutant mice had on average less than 50/% of the number of 
RGCs compared to controls (Fig. 1.22).
Fig.1.22 Age-dependent loss of retinal ganglion cells in O paIenul+ mice.
(A-F) Whole mount retina preparation of O palma and control mice following injection of 
hydroxystilbamidine into the superior colliculus that enables the specific labelling o f retinal ganglion cells. 
Opalenul+ mice (A,C, E) show a reduced number o f labeled cells in comparison with age-matched wild-type 
littermates (B, D, F) that progresses with age (A, B: 2 months; C, D: 9 months; E, F: 13 months) (from 
Alavi et al., 2007).
In invertebrate models of ADOA: Caenorhabditis elegans and Drosophila melanogaster, 
the prominent feature was the high oxidative stress, which could be counteracted by anti­
oxidant treatment (Kanazawa et al., 2008; Yarosh et al., 2008). These two models suggest 
that over production of reactive oxygen species (ROS) may contribute to the pathogenesis 
of ADOA and that anti-oxidant treatment may be beneficial to patients.
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1.5 Summary
Dominant optic atrophy (ADOA) is the most prevalent inherited optic neuropathy 
characterized by a loss of visual acuity, development of centrocoecal scotoma and 
bilateral temporal atrophy of the optic nerve. Post-mortem histopathological studies of 
two patients identified a selective loss of retinal ganglion cells and loss of myelin. About 
60% of ADOA cases are now linked to mutations in the OPAl gene, which encodes a 
dynamin-related GTPase involved in mitochondrial morphology, cristae organization and 
apoptosis. OPAl controls inner membrane fusion, which by counteracting fission 
maintains the morphology of mitochondrial network in dynamic balance. Loss of OPAl 
function is induced by dissipation of the mitochondrial membrane potential and the pro- 
apoptotic process and can result in the increased autophagy of defective mitochondria. 
However, the link between OPAl dysfunction and the clinical manifestations of ADOA 
has not been fully explained yet. It still remains unclear why the disease in its classic 
form is restricted to the apparent ocular phenotype.
In order to help with these unanswered questions, a new mouse targeted Opal mutant has 
been produced, which carries a nonsense mutation in exon 8  causing a reduction in the 
cellular Opal level. Homozygous mutant mice die at the embryonic stage, while 
heterozygous mutant mice develop late and slowly progressive optic neuropathy with the 
reduction in visual function. Of most importance is that by 24 months of age loss of axons 
in the optic nerve is accompanied by abnormalities in mitochondrial ultrastructure and 
increased autophagy.
1.6 Project objectives (Fig.1.23)
The main aim of this PhD project was to study the magnitude of mitochondrial 
dysfunction and cellular response to the reduction in Opal level in Opal mutant mice. 
Cell growth and susceptibility to oxidative stress, morphology of mitochondrial network, 
cristae and mitochondrial membrane potential were studied. In addition, histological 
evaluation of RGC loss and apoptotic staining in aging animals was performed. The 
purpose of these experiments was to give possible insight into the impaired cellular 
mechanisms which lead to visual defects and an optic atrophy in Opal mutant mice.
48
O uter
-M wnbran*
Opal location
Mitochondrial 
dynamics (fusion)
Structural (cristae) 
organization
Membrane potential
Opal function
increasing cell 
viability 
with Opal
Opal level
ADOA mouse model
Optic atrophy
Fig. 1.23 PhD project. ADOA mouse model with Opal deficiency has been 
used to study mitochondrial and cellular dysfunctions, which could lead to 
visual defect and an optic atrophy in mutant mice.
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2. MATERIALS AND METHODS
2.1 Breeding strategy
Opa\+/- “founder” mice were crossed with C57Bl/6JCrl mice (Charles River, UK) to 
move the mutation to a C57Bl/6JCrl background. This was continued at F2 to F5. For 
embryo generation matings were assumed to take place at midnight, and the day of plug 
detection was designated 0.5 days post coitum (dpc). Embryos were dissected daily from 
pregnant dams at 13.5 dpc. The number of animals maintained in the Opal colony was 
approximately 100-150 at any one time. Animals were on a normal controlled 12hr-12hr 
light-dark cycle. 3-4 week old animals were weaned and genotyped. Breeding, 
maintenance and sacrifice were in compliance with the ARVO Statement for the Use o f 
Animals in Ophthalmic and Vision Research.
2.2 DNA extraction and quantification
DNA was extracted from mouse tail (Wizard SV Genomic DNA Purification System, 
Promega, UK) according to the manufacturer's protocol. Tails of approximately 0.3-0.5 
mm long were lysed in 275pl Digestion Solution Master Mix (see Appendix 1) containing 
Proteinase K 20mg/ml (Bioline, UK) at 55°C in the oven overnight. Next digested tissues 
were centrifuged and the supernatants were taken to the subsequent procedures. 250pl of 
Wizard SV Lysis Buffer was added to each sample. Warm lysates were loaded onto the 
columns and centrifuged 1550g for 3min, the flow-through was discarded. Columns were 
washed with ethanol four times and bound DNA was eluted with 500pl of sterile and 
distilled water. 2pl of DNA were added to PCR (polymerase chain reaction) mix (Bioline, 
UK) for genotyping. For some samples DNA was quantified by UV spectrophotometry 
(U- 2800 Spectrophotometer, UV Solutions software, Hitachi, Japan). 1:20 dilutions were 
prepared and samples absorbance measured at 260nm and 280nm. DNA concentration 
was calculated by the formula: C= A260 x dilution x 50pg/ml. Purity of the total DNA was 
assessed by spectrophotometric ratio A260/A280 (1.9-2.1).
Alternatively mouse tails were lysed in 200pl DirectPCR Lysis Reagent (Tail) (Viagen 
Biotech, US) with 0.4mg/ml Proteinase K (Bioline, UK) at 55°C for 5hr to overnight until 
no tissue clumps were observed. Crude lysates were incubated in the water bath at 85°C 
for 45min and stored at 4°C for PCR genotyping. For PCR lpl of lysate was used. For 
embryo genotyping DNA from mouse embryos was extracted by DirectPCR Lysis 
Reagent (Ear) (Viagen Biotech, US).
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2.3 Opal and Nnt genotyping
2.3.1 Opal allele-specific genotyping
For genotyping of Opal mutant animals two reactions were carried out with two sets of 
primers. The forward primer 5’-TCTCTTCATGTATCTGTGGTCTTTG-3’ was identical 
for both reactions amplifying wild-type and mutant allele. Reverse primers: 
5 ’ -TT ACCCGT GGT AGGT G ATC AT G-3 ’, 5 ’ -TT AC C CGT GGT AGGTG ATC AT A-3 ’
were designed to bind specifically to the WT and a mutant allele, respectively. Primers 
were designed with Primer3 software (Whitehead Institute for Biomedical Research, US). 
PCR reactions were run on TC-512 Techne Thermal Cycler (Techne Inc., US) For each 
reaction 2pl of DNA template from individual animal were used. DNA was amplified 
with lpmol/pl primers in 25pi reaction PCR mix (BioMix Red; Bioline, UK). 
Additionally, a control reaction without DNA template for each assay was carried out. 
PCR was performed with initial denaturation for 5 minutes at 94°C followed by 35 cycles 
of denaturation (1 minute at 94°C), annealing (1 minute at 55°C) and elongation (1 minute 
72°C) after which the final elongation was carried out for 10 minutes at 72°C. PCR 
products were separated by 2% agarose gel electrophoresis in TBE buffer (Tris-borate- 
EDTA (Materials and Methods 2.4 and Appendix 1). 5pi of lOObp DNA ladder 
(Invitrogen) were loaded into the well for size determination.
2.3.2 Nnt genotyping
Mice were genotyped by PCR of missing exons 7 and 11 of Nnt gene. Primer sequences 
were taken from Freeman et al., 2006 and were for Nnt exon 7:
Nnt7 forward 5’- GTGCATTGAACCCTCAAAGG-3’
Nnt7 reverse 5 ’ -C AGGT AAG AAAGCT CCT GTTTT-3 ’; 
for Nnt exon 11:
Nnt 11 forward 5,-TCCTGCTATTCCTCCTCCTG-3’
Nntll reverse 5 ’ - GCT GCCTT G ACTTT GG AT ATT-3 ’.
Primers 6L4 and 12L1 (taken from Ting-Ting Huang et al., 2006) flanked the deletion in 
Nnt gene. Their sequence was for 6L4: 5’- TCCCCTCCCTTCCATTTAGT-3’ and 
12L1: 5’- GTAGGGCCAACTGTTTCTGC-3’. Primers were used at the concentration 
lpmol/pl. PCR was performed on TC-512 Techne Thermal Cycler (Techne Inc., US) in 
25 pi reaction mix (BioMix Red; Bioline, UK). PCR products were separated by 2% 
agarose gel electrophoresis (see Materials and Methods 2.4).
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2.4 Agarose gel electrophoresis
Agarose (Invitrogen) was dissolved in 100ml TBE buffer in a microwave oven. After 
cooling the solution to about 60°C ethidium bromide was added to the final concentration
0 . 5  fig/ml and the solution was poured to the casting tray containing a sample comb and 
was allowed to solidify at the room temperature for lhr. 12pl of PCR samples were 
loaded into the wells. Electrophoresis was run in the electrophoresis chamber with the gel 
completely covered with TBE buffer for about lhour at 75-120V. DNA fragments were 
visualized by UV light (UVITECH transilluminator).
2.5 Denaturing agarose gel electrophoresis
To check the integrity of extracted RNA samples, 5pi of the samples were heated in lOpl 
RNA sample loading buffer (Sigma) at 65°C for 1 Omin, chilled on ice and loaded onto the 
1.2% denaturing (formaldehyde) agarose gel (see Appendix 1). Electrophoresis was run at 
5V/cm in formaldehyde MESA buffer (MOPS-EDTA-sodium acetate; see Appendix 1). 
RNA bands were observed under UV light.
2.6 Primer design and specificity
Primers were designed using Primer3 software. A transcript sequences in FASTA format 
were retrieved from NCBI database (National Center for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov/) and the default settings for primer design were used: an 
optimal primer size 20bp, an optimal melting temperature 60°C. Primers were stored at 
-20°C at the concentration lOOpM diluted in TE buffer (Tris- EDTA; see Appendix 1) or 
in MilliQ H2O.
2.6.1 Primer design for qRT-PCR (quantitative reverse transcription PCR)
Each set of primers targeted a coding region of mRNA sequences that were obtained from 
NCBI database (Table 2.1).
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Primers Sequence 5’-3’
Mus musculus Mfn2 Forward 
Mus musculus Mfn2 Reverse
Mus musculus Spg7 Forward 
Mus musculus Spg7 Reverse
Mus musculus Bik Forward 
Mus musculus Bik Reverse
Mus musculus Dnm 11 Forward 
Mus musculus Dnm 11 Reverse
Mus musculus Slc25a4 Forward 
Mus musculus Slc25a4 Reverse
Mus musculus Atp5k Forward 
Mus musculus Atp5k Reverse
Mus musculus Hprtl Forward 
Mus musculus Hprtl Reverse
AT GCAGACGGAGAAGCAGTT 
GGCAGACACGAAGAAGATCC
CACCTCAAGGATGAAGCAGA
AGGAAATACTGCCCCCACTT
GAAGGAGCCTGTGAGAGACG 
GTTTT CCCTGAGGTT GGT G A
TTTGCTCGTGTGAAGACTGG 
T GG AGCTTCCTTT CT G AGG A
G ATCG AG AGGGT C A AACT GC 
G AAGTT C AGGGCTT G AGT GG
CGGTTCAGGTCTCTCCACTC 
CGCC AGTT CT CT CTC AAT CC
AGCTACTGT AAT GAT C AGTC AACG 
AG AGGT CCTTTT C ACC AGC A
Table 2.1 Primer sequences for qRT-PCR analysis.
2.6.2 Melting curve analysis
To check the specificity of the primers, cDNA samples were prepared in serial dilutions 
and SYBR Green based real time RT-PCR was performed using conditions that were 
experimentally optimized for each set of primers (see 2.8.3). PCR was followed by a 
melting step with default conditions (the temperature range 50°C -99°C). A melting curve 
was obtained by plotting the derivative of the fluorescence with respect to temperature 
(idF/dT) (Rotor-Gene™ 6000 instrument, Melt Report).
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2.7 RNA preparation
2.7.1 Isolation of RNA
Tissues (retina, kidney, liver, spleen) were dissected from WT and heterozygote animals 
and RNA was extracted using Rneasy Mini Kit (Qiagen). Two retinas were pooled into 
one sample. Tissues were placed in RNA later (Sigma) and stored at -20°C until 
extraction was performed. On the day of extraction tissue was transferred to 600pl of 
Buffer RLT and homogenized immediately until the sample was uniformly homogeneous 
(20-40s). Homogenate was centrifuged at 15000g for 3min and supernatant was 
transferred to a new 1.7ml tube by pipetting. 600pl of 70% ethanol was added to the 
lysate and mixed by pipetting. A 700pl sample was applied to an RNeasy mini column 
placed in a 2ml collection tube and the sample was centrifuged for 15s at 9000g. Flow­
through was discarded. The step was repeated with the rest of the sample. Next each 
column was washed with 350pl buffer RW1, centrifuged for 15s at 9000g and the flow­
through was discarded. To avoid DNA contamination samples were treated with DNase. 
For each sample lOpl DNase I stock solution (Qiagen) was added to 70pl Buffer RDD 
(Qiagen) and mixed by gently inverting the tube. The Dnase I mix was pipetted directly 
onto a silica-gel membrane and placed on the benchtop (20-30°C) for 15min. Afterwards 
the columns were transferred onto new collection tubes, 500pl Buffer RPE was pipetted 
onto the column followed by centrifugation for 15s at 9000g to wash the column. The 
flow-through was discarded. Another 500pl Buffer RPE was added to the column and 
centrifuged for 2min at 9000g to dry the silica-gel membrane. For RNA elution the 
column was transferred to 1.7ml collection tube and 40pl TE was added directly onto the 
silica-gel membrane and centrifuged for lmin at 9000g.
2.7.2 Measurement of RNA quantity and quality
2.7.2.1 RNA quantification by spectrophotometry
For RNA quantification 1:20 dilutions were prepared and the samples’ absorbance was 
measured at 260nm and 280nm using Spectrophotometer U- 2800 equipped with UV 
Solutions software. Purity of the RNA was assessed by spectrophotometric ratio 
A260/A280 (1.9-2.1). RNA concentration was calculated by the formula:
C= A260 x 20 x 40jig/ml
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2.7.2.2 RNA quantification using RiboGreen
RNA concentration was measured using the fluorescent reagent RiboGreen (Molecular 
Probes, Inc., Eugene, Oregon, US). A standard curve was prepared with the ribosomal 
RNA (16S and 23S rRNA): 100pg/ml was diluted in TE to make the 2pg/ml stock 
solution and stored at -20°C. On the day of the experiment, the RiboGreen reagent was 
diluted 200-fold in TE and lOpl was added to lOpl of RNA standard different dilutions to 
obtain the final RNA concentrations: lpg/ml, 750ng/ml, 500ng/ml, 250ng/ml and blank 
(no RNA added). Samples were mixed and incubated for 5min at room temperature, 
protected from light. The experimental RNA samples were diluted 50 fold in TE to a final 
volume of 10ja.l and 10pl of RiboGreen reagent was added to each sample.
Samples were mixed well and incubated at room temperature for 5min, protected from 
light. All samples were prepared in duplicate. The fluorescence of the samples in the final 
volume of 20pl was measured and the standard curve was generated using Corbett Rotor- 
Gene 6000 (software version Rotor-Gene 1.7.34, Concentration Measurements).
The program default setting was:
Hold 50°C - 2min
Cycling 10 repeats- 50°C hold 5s
Fluorescence was acquired to the Green Channel with the fluorescein excitation and 
emission wavelengths: ~480nm and 520nm, respectively. The instrument’s gain was 
automatically set according to the concentration of the reference sample on the first 
position in the rotor: the RNA standard at the highest concentration. The value of the 
reagent blank was subtracted from that of each sample and obtained concentrations were 
multiplied by the dilution factor 50 (Appendix 2).
2.8 Reverse transcription (RT) and PCR
2.8.1 First strand cDNA synthesis
For cDNA synthesis (for qRT-PCR) 200ng of total RNA was mixed with lpl (270ng)
oligo (dT)ig primers and lpl dNTP mix: dATP, dGTP, dCTP, dTTP, lOmM each
(Bioline, UK) in the total volume of 13pl. Next, the mixture was heated to 65°C for 5min
and incubated on ice for lmin. Afterwards 4pi 5x First Strand Buffer (Invitrogen),
lpl 0.1M DTT (Invitrogen), lpl RNase Inhibitor lOU/pl (Bioline) and
lpl Superscript III RT 200 U/pl (Invitrogen) were added to each tube followed by lhr
incubation at 50°C. The enzyme was inactivated by heating at 70°C for 15min.
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2.8.2 RT- PCR of Opal transcript isoforms
For RT-PCR of Opal transcript isoforms cDNA was synthesized on the template of lpg 
of RNA. PCR amplification was performed on TC-512 Techne Thermal Cycler (Techne 
Inc., US) in 25pl reaction mixture containing 2pi cDNA, lpM primers forward and 
reverse, 12.5pl 2x BioMixRed (Bioline, UK).
The PCR conditions were identical for all designed primers:
Initial denaturation 5min 94°C
35 cycles:
1. Denaturation
2. Annealing
3. Elongation 
Final elongation
30s 94°C 
lmin 54°C 
lmin 72°C 
lOmin 72°C
2.8.3 Quantitative PCR amplification of cDNA- AACt method 
The relative expression of genes was calculated on the basis of AACt values (Livak and 
Schmittgen, 2001). The method assumes an optimal doubling of the target DNA during 
each performed real time PCR cycle. The Ct is determined for each sample to compare the 
distinct cycle differences between samples at the selected level of fluorescence.
Real time PCR was performed on a Rotor-Gene™ 6000 instrument (Corbett Research) in 
SYBR Green JumpStart Taq Mix (Sigma) containing 200nM primers and 2 pi cDNA 
sample. The PCR conditions were as follows:
Hold 2min 95°C 
Cycling (40 cycles):
1. Denaturation 15s95°C
2. Annealing 20s 58°C
3. Elongation 20s 72°C
Hold 2min 72°C
For each run standard curves were prepared for both GOI (gene of interest) and reference 
gene (housekeeping gene) with four dilutions and the blank (negative control). All 
samples were run in duplicate. The AACt method relies on “identical” efficiency of 
amplification (E) between GOI and the reference gene. The E was automatically 
calculated and the differences in efficiencies were estimated. The Ct threshold was 
automatically set in the exponential phase and Ct values for all samples were calculated.
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The expression of GOI was normalized to the expression of the reference gene and the 
results were calibrated to those of the first WT sample.
2.9 Mitochondrial isolation from mouse tissue
Mitochondria were isolated using a Mitochondria Isolation Kit (Sigma). All steps were 
performed on ice; samples were centrifuged at 4°C. Freshly excised mouse tissue (120mg 
brain, 6  retinas and optic nerves) was washed twice in ice-cold Extraction Buffer (lOmM 
HEPES, pH 7.5, 200mM mannitol, 70mM sucrose, ImM EGTA). Next tissue cut into 
small pieces was homogenized on ice with 1.5ml Extraction Buffer containing 2mg/ml 
albumin in a precooled 3ml volume glass homogenizer by moving the pestle up and down 
25 times. Homogenate was transferred to 2ml Eppendorf tube and centrifuged at 600g for 
5min. Supernatant was recovered and centrifuged at 1 lOOOg for lOmin. For brain samples 
the resulting pellet was resuspended in 1.5ml Extraction Buffer and two centrifugation 
steps were repeated. Mitochondria in the pellet were suspended in 80pl (mitochondria 
isolated from brain) or lOpl (retina) Storage Buffer (lOmM HEPES, pH 7.4, 250mM 
sucrose, ImM ATP, 0.08mM ADP, 5mM sodium succinate, 2mM K2HPO4 , ImM DTT). 
Mitochondrial protein concentration was quantified using absorption spectroscopy 
methods: colorimetric DC Protein Assay (Bio-Rad) or UV spectrophotometric assay 
(Picodrop) (see 2.10) Mitochondria were aliquoted and stored in -80°C.
2.10 Protein quantification
2.10.1 DC protein assay (Bio-Rad) - colorimetric method
Mitochondrial suspension and the gamma globulin standard were diluted in 2% SDS. For 
the standard fresh dilutions: 0, 0.05, 0.1, 0.15, 0.2, 0.29, 0.5 mg/ml in triplicate were 
prepared. 5pi of standards and samples were pipetted into wells of a 96-well plate. 25 pi of 
reagent A containing reagent S were added into each well followed by 200pl of reagent 
B. After 15min the plate was placed in a plate reader and was shaken for 5s at medium 
speed. The absorbance was measured at 750nm (Multiskan Ascent, Labsystems, Finland). 
The concentration of the samples was extrapolated from the standard curve (Fig.2.1).
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Protein Quantification
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Fig.2.1 A standard curve for protein quantification assay
2.10.2 UV spectrophotometric assay 
Mitochondrial concentration was calculated from the absorbance values at 280nm using 
Picodrop UV/VIS spectrophotometer (Picodrop Limited, UK). The absorbance of 3pl of 
mitochondrial suspension was measured in disposable pipette tips provided by the 
company. The IgG (immunoglobulin G) was used as an internal reference protein. The 
average of three readings was taken (Appendix 2).
2.11 Protein extraction from mouse embryonic fibroblasts (MEFs)
For the whole cell extraction cells were culturing in T25 flasks (Triple Red, UK). The cell 
medium was removed and cells were rinsed with ice cold PBS buffer (phosphate buffered 
saline, see Appendix 1). To lyse cells 0.8ml of ice cold RIPA (Radio- 
Immunoprecipitation Assay; Sigma) buffer containing a complete protease inhibitor 
cocktail (tablets, Roche) was added and cells were gently rocked on ice for 15min. Next 
the cells were scraped and transferred into microcentrifuge tubes on ice. Cells were 
further disrupted by passing the lysate 5 times through a 21-gauge needle. The protein 
supernatant was collected after centrifugation at 8000g for lOmin at 4°C. Protein extract 
aliquots were stored at -80°C. Care was taken to avoid freeze-thaw cycles.
2.12 Western blotting
Protein samples were boiled for 5min at 95°C in a sample loading buffer (Appendix 1). 
20pg of protein extracts were separated by 8% SDS-PAGE (sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis) in Tris/Glycine/SDS running buffer (Bio-Rad).
The composition of the resolving (8%) and stacking (5%) gels is described in Appendix 1. 
The Precision Plus Protein Standard (Bio-Rad) was loaded in a volume of 10pl/ lane to
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show the location of proteins at the distinct size in the gel. Electrophoresis was run for 
lhrl5min at 100V followed by transfer to 0.2pm nitrocellulose membrane (Bio-Rad) for 
lhrl5min at 250mA in a cold Tris/Glycine transfer buffer (Bio-Rad) with 20% methanol 
(v/v). After the transfer, membranes were blocked with 5% milk in TBST (Tris-Buffered 
Saline (tablets, Sigma) with Twin 20 (0.05% v/v)) for lhr at room temperature.
The membranes were incubated with the primary monoclonal mouse Opal antibody (250 
pg/ml BD Biosciences) in dilution 1:1000 in 1% milk in TBST. The membranes were 
washed three times in TBST and incubated for another hour with the secondary goat anti­
mouse antibody conjugated with HRP, diluted by 1:10000 in 1% milk in TBST. After 
three washing in TBST blots were subjected to chemiluminescent detection with Pierce 
ECL Western Blotting Substrate (Pierce) for lmin and exposed to blue sensitive 
radiographic film (Kodak). Immunoblot for Hsp60 was done on the same blot as for opal 
protein. The blot was cut in a way that these two proteins were separated and could be 
incubated with their specific antibodies. The primary antibody for Hsp60 was diluted by 
1:1000 followed by incubation with the goat anti-mouse secondary antibody (1:10000). 
The cytochrome c mouse antibody (BD Pharmingen) was used in dilution 1:1000.
2.13 Analysis of the cell number in RGC layer and the retinal thickness
10 retinal cross sections of 24-month old Opal +/+ and Opal +/- mice (n=5) were 
mounted and stained with haematoxylin and eosin (H&E). These sections were collected 
from 5 areas that were 20 sections apart. Images of the whole retina were obtained using a 
Leica DMRA2 microscope equipped with a DC500 camera (Leica) and QWinV3 
software.
The mounting, staining with H&E and imaging was carried out by Vanessa Davies.
Counts of cells in retinal sections were done manually by counting all nuclei in the RGC 
layer. The mean retinal thickness in retinal cross sections was obtained by taking the 
measurements across the thickest region of the retina in 5 areas as above.
2.14 Apoptotic assay on the mouse retina
Retinal sections from 2 year old animals (3 WT and 3 heterozygote) which had been 
embedded in wax were used for apoptosis assay-TUNEL assay using Apoptag 
Fluorescein In Situ Apoptosis Kit (Chemicon). Six sections per genotype were analyzed. 
For positive control sections were pre-treated with lpg/pl Dnase (Qiagen). Sections 
where the TdT enzyme was omitted were negative control.
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All sections were deparaffinized with xylene three times for 5min and then washed in 
decreasing concentrations of ethanol: 100% twice for 5min, 95% for 3min and 70% for 
3min.
Dewaxed sections were washed in PBS for 5min, incubated in 0.1% TritonX-100 for 
15min followed by two washes in PBS for 2min. Then for positive control, sections were 
incubated in 1 pg/pl Dnase for 30min and rinsed in dthO 5 times for 3min each wash. 
Equilibration buffer was applied to all sections for 5min at room temperature followed by 
lhr incubation at 37°C with 30pi TdT enzyme for each section. After incubation 
Stop/WASH Buffer was applied for lOmin and then rinsed with 3 changes of PBS for 
lmin. 30pl of warmed Anti-Digoxigenin antibody conjugated with fluorescein was 
applied to the sections and incubated in a humidified chamber for 30min at room 
temperature. The chamber was covered with aluminium foil to protect from light. The 
sections were rinsed in PBS 4 times for 2min, counterstained with Hoescht 33342 
(Invitrogen) and mounted with Hydromount (National Diagnostics) under glass 
coverslips. The slides were stored at 4°C. Pictures were taken with a DM6000B 
microscope equipped with CFC350FX camera and LAS AF6000 software under DAPI 
and fluorescein filters (Leica, Germany).
2.15 Mitochondrial membrane potential measurement
Membrane potential was measured in isolated mitochondria by JC-1 staining and analysis 
of JC-1 dye fluorescence at 595nm in an F-4500 fluorescence spectrophotometer (Hitachi 
High-Technologies, Tokyo, Japan). The excitation wavelength was set at 490nm. Assay 
was performed in a quartz cuvette with a 10mm optical pathway. 50pg of mitochondrial 
proteins suspended in a Storage Buffer (Sigma) were added to 1.9ml JC-1 Assay Buffer 
(Sigma) to total volume of 2ml. After addition of 2pi JC-1 Stain (Sigma), the sample was 
mixed by inversion and left at room temperature in the dark (covered with aluminium 
foil) for 7min to allow complete uptake of JC-1 dye into the mitochondria. The blank 
fluorescence measured in a cuvette with Assay Buffer lacking mitochondrial fraction was 
subtracted from the fluorescence of each sample.
2.16 Isolation of mouse embryonic fibroblasts (MEFs)
Two pregnant females were sacrificed at day 13.5 post coitum (assuming 0.5 day is the 
first day the plug is observed) by cervical dislocation and uterine horns were placed in 
DMEM (Dulbecco’s modified Eagle’s medium; Invitrogen) on ice. Each embryo was
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placed into a petri dish containing PBS, and then separated from the placenta and 
surrounding membranes using a Leica MZ10F dissecting microscope (Leica, Germany). 
Tissue (head) was collected for Opal genotyping and internal organs were cut away. The 
embryonic tissue was minced with a sterile razor blade in minimal amount of DMEM 
followed by lOmin incubation in 0.25% trypsin/EDTA (Invitrogen) in a waterbath at 
37°C. After neutralization of trypsin by suspension of cells in DMEM supplemented with 
10% fetal bovine serum (FBS; Biosera, UK) the cells were transferred to T75 flasks 
(Triple Red, UK) with 15ml DMEM with 10% FBS and Antibiotic-Antimycotic solution 
(Invitrogen) and left for two days to attach to the dish.
2.17 Mitochondrial staining with Mitotracker
MEFs were grown on coverslips (Agar Scientific) in a 24-well plate (Triple Red, UK) in 
DMEM medium with 10% FBS. The DMEM medium was then removed and replaced by 
a medium containing 150nM Mitotracker Red (Mitotracker Red CMX-Ros; Molecular 
Probes) and 5pg/ml Hoescht 33342 (Invitrogen). After 30min incubation at 37°C, the 
cells were fixed at 4% paraformaldehyde (Sigma) in PBS for 15min at 37°C, rinsed in D- 
PBS (Dulbecco’s phosphate-buffered saline; Invitrogen) three times and incubated in 
0.1% Triton X-100 in PBS for 5min at room temperature. After three washes in D-PBS 
for 5min cells were mounted in non-fluorescing hydromount (National Diagnostics, UK). 
Pictures were taken with a DM6000B microscope equipped with CFC350FX camera and 
LAS AF6000 software under rhodopsin and DAPI filters (Leica, Germany).
2.18 Mitochondrial morphometry
Morphometric evaluations were performed using ImageJ (freely available image 
processing program, http ://rsb. info .nih. gov/ii 1. The scale was calculated and the length of 
mitochondrial particles (perimeter) was measured manually according to the scale: 
ljjm=10.8 pixels. At least 25-50 measurements in each cell were recorded. Based on the 
obtained results mitochondrial morphology was classified into three categories: tubular, 
intermediate, fragmented and each cell was assigned to one of these categories.
2.19 Assessment of cell proliferation
MEFs were cultured in DMEM with 10% FBS in 6-well plates. MEFs were seeded at the 
density ~ 2xl05 cells in each well. Every third day MEFs were collected by trypsinization 
and counted in a haemocytometer. Counting was carried out on two wells from each
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culture. Afterwards cells were seeded at the same density ~ 2x105. Population doubling 
(PD) was calculated according to the equation: PD= (logY- logX)/log2, Y=final cell 
count, X= inoculation cell count.
2.20 Light treatment protocol
MEFs were seeded onto a 96-well plate at the density ~ 2xl04 cells in each well and 
incubated at 37°C. Before the day of the experiment the medium was replaced with the 
fresh DMEM with 2% FBS. Next day cells were exposed to the blue-filtered light (Lee 
filters) in SF10PF medium (a modified Ham’s F10 without photosensitizers, such as 
phenol red, tryptophan, tyrosine, riboflavin, and folic acid; Schiitt et al., 2000, Appendix 
1) for max. 24 hours at the irradiance of 2.3 mW/cm2. Fig.2.2 presents the spectrum of the 
light used. The temperature was maintained at 30°C. For control the plate was protected 
from light by wrapping it with black paper.
Light spectrum0,25 i
0,20
8 0,15
0,05
530 580
Wavelength
630 680 730 780380 430 480
Fig.2.2 The spectrum of light used for irradiation of MEFs
After irradiation the cells were washed twice in D-PBS followed by a survival test (MTT 
assay, see 2.22) in DMEM supplemented with 10% FBS.
2.21 Hydrogen peroxide (H2O2) treatment protocol
MEFs were treated with one single dose of H2O2 . MEFs cultured in DMEM with 2% FBS 
overnight in 96-well plates were rinsed once with D-PBS and treated with different 
concentrations of H20 2 in DMEM: 0.1, 0.2, 0.5, 0.8, ImM for 1 and 2hr. For the control, 
cells were incubated with DMEM without H2O2 . Afterwards the cells were rinsed twice in
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D-PBS and DMEM with 10% FBS was added to each well. Cell viability was measured 
in MTT assay (2.22).
2.22 Measurement of cellular viability
MEFs were subjected to the appropriate treatments (2.20 and 2.21) in 96-well plates and 
then MTT (Thiazolyl Blue Tetrazolium Bromide; Sigma) was added to the wells at a final 
concentration of 1 mg/ml for 2.5 hours at 37°C. Afterwards the medium was removed and 
reduced MTT was solubilized by adding lOOpl of acidified (0.06N HC1) isopropanol. 
Absorbance was measured at 590nm and 690 nm (reference wavelength) on the 96-well 
plate reader (BioTek Instruments, US).
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3. BREEDING STRATEGY AND GENOTYPING OF OPA1 +/- MOUSE MODEL
3.1 Introduction
An Opal mouse model for Autosomal Dominant Optic Atrophy has been generated by 
ENU-mutagenesis (see 1.4.2). The putative disease-causing nonsense mutation in exon 8 
coding for a C to T transition at 1051 bp of Opal gene was predicted to cause protein 
truncation (Gln285 to Stop: Q285X).
All animals in the colony were bred on a mixed C57BL/C3H background (FI) and the 
experiments were performed on mice bred at generations F2 to F5 (Materials and 
Methods 2.1). The paternal line C3H/HeJ is homozygous for the retinal degeneration 1 
mutation (rdl) in the phosphodiesterase 6B gene (Pde6brdI, ID: MGI: 1856373 Mouse 
Genome Informatics). This mutation causes blindness by weaning age and was gradually 
removed from animals by crossing them with the C57BL strain, genotyping for rdl and 
only breeding selectively to eliminate the mutant rd allele. Thus none of our experimental 
animals were affected by retinal degeneration.
C57BL/6J is the most widely used inbred strain and was used for outcrossing in our line. 
During the course of this work it was found that this strain has a spontaneous deletion in 
nicotinamide nucleotide transhydrogenase gene (tV«/C57BL/6J, ID: MGI: 3626282 Mouse 
Genome Informatics), which causes glucose intolerance and impaired insulin secretion 
(Toye et al., 2005). This strain was used for outcrossing with the C3H strain and 
producing consecutive generations of Opal mice on an increasing C57BL background. 
The number of animals maintained in the Opal colony was approximately 100-150 at any 
one time. Animals were on a normal controlled 12hr-12hr light-dark cycle. 3-4 week old 
animals were weaned and genotyped (Materials and Methods 2.2).
The objective of this Chapter is to present two strategies that were used for Opal mice 
genotyping and the method for breeding out an unwanted mutation in the Nnt gene, which 
was inherited from C57BL/6J strain.
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3.2 Genotyping of Opal +/- mouse by allele-specific PCR
3.2.1 Allele-specific PCR amplification of DNA samples
This method was the primary method for Opal genotyping. Details about DNA 
extraction, primers sequences and PCR conditions are described in Materials and 
Methods 2.2; 2.3.1.
The method required two separate reactions to be carried out with two sets of primers. 
The forward primer was identical for both reactions amplifying wild-type and mutant 
allele. Reverse primers were designed to bind specifically to a sequence with or without 
mutation to allow amplification of mutant and wild-type alleles respectively in separate 
reactions. The product size did not vary from wild type allele to mutant allele. Fig. 3.1 
presents a 2% agarose gel of PCR-amplified Opal gene fragments 150bp long. Top row: 
mutant allele, bottom row: WT allele. Samples that were run from top and bottom wells 
in the same line represent one animal. Samples 2, 3, 8, 11, 12 are wild type Opal mice 
because in these samples the mutant allele was not PCR-amplified.
Animal 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
^  Opal +/- allele
^  Opal +/+ allele
Fig.3.1 Opal mouse model genotyping by allele-specific PCR.
PCR amplification of DNA samples was followed by 2% agarose gel electrophoresis. 
12pl of PCR products were usually loaded onto gel wells. DNA samples were labelled
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with Ethidium Bromide, which was added to the agarose gel before electrophoresis 
(Materials and Methods 2.4 ). Fluorescence of the samples was observed under UV light.
3.3 Designing of a new method for Opal genotyping
3.3.1 High Resolution Melt Analysis- Introduction
A new protocol was designed for Opal mouse genotyping based on High Resolution Melt 
(HRM) Analysis performed on a Rotor-Gene™ 6000 instrument (Corbett Research).
High Resolution Melt is a post-PCR analysis that can be used to differentiate between 
different PCR sequences due to their different thermal denaturation properties. Mutations 
are detected as either a shift in the melting temperature (Tm) or a change in the shape of 
the melting curve measured as a change in the level of fluorescence of DNA intercalating 
dye. For DNA genotyping, first DNA is amplified by PCR followed by denaturation of 
DNA duplex during HRM programme and data analysis.
3.3.2 Primers design
The assay design criteria found in the High Resolution Melt Assay Design and Analysis 
booklet (Corbett Research) recommended using primers that will amplify short products 
(100-250bp) because longer products may decrease sensitivity of the assay due to 
increased potential for multiple melt domains. Primers were designed using Primer3 
software (Materials and Methods 2.6). They amplified lOObp fragment of Opal gene and 
flanked the mutation inserted into this gene (Table 3.1)
Primer Sequence Location
forward TTCTGAAGTTCTTGATGTTCTTTCTG Exon 8
reverse CT G AC AGC AGGTCCTGGT CT AT Intron between exons 8/9
PCR amplified OPA1 fragment
5 ' TTCTGAAGTTCTTGATGTTCTTTCTGATTATGATGCCAGTTACAAT
ACAC/TAAGATCACCTACCACGGGTAAGGGGAAAATAGACCAGGACCTGCTGTCAG 3 '
Table 3.1 Primer sequences and Opal fragment amplified in PCR reaction.
Primers (red) amplified 1 OObp fragment which flanked Opal mutation (blue)
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3.3.3 PCR and HRM protocol
High Resolution Melt Analysis (HRM) was performed using Corbett Research Instrument 
and Rotor-Gene 6000 Series Software. The reaction mix was prepared as shown in Table 
3.2.
Reaction mix per 25 pi
dH20 15.1 pi
1 Ox PCR buffer (Qiagen) 2.5 pi
lOmM dNTP mix 2 pi
4pM F Opal lOObp 1.7 pi
4pM ROpal lOObp 1.7 pi
50 pM SYTO dye (Invitrogen) 0.75 pi
Hot Star Taq 5U/pl (Qiagen) 0.25 pi
Table 3.2 Reaction mix for OPA1 genotyping by High Resolution Melt Analysis.
The reaction mix was prepared for n samples and a lpl mouse genomic DNA template 
was added to each tube to the final volume 25pl.
Genomic DNA template was obtained either from mouse tail or from embryonic tissue at 
E l3.5 (Materials and Methods 2.2) and lpl was taken to the reaction. The reaction was 
run in a 96-well carousel in 0.1 ml tubes. Total volume for each sample was 25pi. Each 
run had a control sample without DNA template and positive control samples from Opal 
+/+ and Opal +/- animals. For PCR amplification primers were used at the concentration 
of 270nM, Taq polymerase at 0.05 U/pl and SYTO dye at the concentration 1.5pM, 
which intercalated into DNA at the saturating level.
DNA samples were PCR amplified in 40 cycles followed by HRM. HRM was performed 
at a of 70-90°C. Denaturation was monitored every 0.1 °C as progressive decrease in 
fluorescence caused by the release of SYTO dye from unfolding DNA double helix. 
Table 3.3 presents setup for PCR and HRM reactions.
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Condition Temperature Time
Hold 95°C 15min
Cycling (40cycles)
Denaturation 95°C 15s
Annealling 57°C 30s
Extension 72°C 30s
HRM 70-90°C rising by 0.1 °C each step
Table 3.3 Setup for PCR & HRM protocol for OPA1 genotyping using Corbett 
Research-Rotor Gene 6000.
3.3.4 Data analysis
Data analysis was performed using the Rotor-Gene™ 6000 instrument HRM Software. 
The raw melting curves were fluorescence-normalized so that all curves had the same 
starting and ending fluorescent signal level. Results show two different denaturation 
curves of Opal DNA fragments obtained from Opal +/+ (red) and Opal +/- animals 
(blue) (Fig.3.2). The results were confirmed by allele-specific PCR method (Fig.3.3).
100
WT80
o
60
Es
Z
40
HET
20
858075
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Fig.3.2 Genotyping results obtained by High Resolution Melt Analysis.
Results from HRM genotyping for Opal +/+ (WT) and Opal +/- (HET) animals.
The graph shows results from the genotyping of 15 animals (DNA samples: 1528-1542).
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A)
No. Sample (colour on HRM) Genotype No. Sample (colour on HRM) Genotype
1 1528 HET 9 1536 HET
2 1529 WT 10 1537 WT
3 1530 HET 11 1538 WT
4 1531 WT 12 1539 WT
5 1532 WT 13 1540 WT
6 1533 HET 14 1541 HET
7 1534 WT 15 1542 HET
8 1535 WT 16 No template control
B)
lOObp
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Fig.3.3 Confirmation of the HRM genotyping by PCR-allele specific method
A). HRM-genotyping results for 15 animals (1528-1542).
B). Results from Opal genotyping (1528-1542 samples) obtained by PCR-allele specific 
method (Materials and Methods 2.3.1; Chapter 3.2). WT (top row) and mutant (bottom 
row) gene fragments 150bp long were stained with Ethidium Bromide on 2% agarose gel. 
The arrow shows the 1 OObp band in the ladder.
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3.4 Inheritance of Nnt mutation from C57BL mouse and breeding out the mutation 
in Opal mouse
Nicotinamide nucleotide transhydrogenase (NNT) is a nuclear-encoded mitochondrial 
inner membrane protein involved in detoxification of reactive oxygen species (ROS), 
couples the generation of NADPH to proton transport and provides NADPH for the 
regeneration of two important antioxidant compounds, glutathione and thioredoxin, in the 
mitochondria (Huang TT et al., 2006). Mutation in the Nnt gene has been reported in 
inbred C57BL/6J mice and underlies the glucose intolerance and impaired (3 cell function 
(JAX® Mice Database, Stock Number 000664, Jackson Laboratory). Mutation causes 
deletion of 17,814 bp region between exons 6 and 12 which results in missing of exons 7- 
11 in Nnt transcript. Mature protein is not detected in these mutants (Huang TT et al., 
2006).
Opal mice inherited the Nnt mutant allele from some C57BL/6J animals -  the parental 
inbred strain that was consecutively used for backcrossing. The Nnt allele was identified 
in Opal animals of the generation F5 but all generations F1-F5 had to be genotyped 
because it was not possible to find out which of the C57BL/6J animals used for mating 
were Nnt deficient. Because of the role of Nnt in mitochondria there was a possibility that 
Nnt may be a genetic modifier that is capable of modulating the degree of potential 
mitochondrial changes caused by the Opal deficiency. Genotyping for Nnt allowed us to 
select Nnt mutation-free mice and breed them for the experiments.
The genotyping strategy consisted of three separate PCR reactions. PCR products were 
separated by 2% agarose gel electrophoresis (Materials and Methods 2.4). Sequences of 
the primers were already published (Materials and Methods 2.3.2). Primers Nnt7 and 
Nnt 11 amplified two different fragments 250bp long in exon7 and exon 11 respectively 
which were deleted in Nnt mutants. (Fig.3.4) These PCRs could select Nnt -/- mutants. 
Primers: Exon6L4 and Exonl2Ll bound to DNA sequences that flank the deleted NNT 
region at opposite ends and produced 547bp fragment only in Nnt mutants. There were no 
products in animals with two wild type Nnt alleles (Fig 3.5).
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Fig.3.4 Results of Nnt genotyping of 60 Opal mice by both Nnt7 and N n tll  primers.
PCR products were separated by 2% agarose gel electrophoresis and stained with 
Ethidium Bromide. Lack of products (labelled by *) selected Nnt -/- animals.
If»
C57BL
Opal Nnt+I+ C3H NTC
Fig.3.5 Results of Nnt genotyping by PCR with 6L4 and 12L1 primers.
A.) The presence o f 547bp bands on 2% agarose gel reveals mutation in at least one 
Nnt allele in Opal animals. No products indicated their Nnt +/+ status.
B.) Confirmation of Nnt +/+ genotype of 4 opal animals from different litters after 
selection o f Nnt+/+ females and males for breeding. Positive control: DNA from a
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C57BL/6J mouse with Nnt mutation, negative control: DNA from C3H mouse 
without Nnt mutation, NTC: no template control
3.5 Discussion
One of the aims of this chapter was to present two strategies used for genotyping Opal 
mice. There is no doubt that the genotyping procedure needed to be reliable because it 
was the key to the interpretation of a Opal mouse model. Both methods (the allele- 
specific PCR and HRM analysis) were interchangeable. HRM is a faster method and as 
opposed to the allele-specific PCR method HRM analysis did not need two primers sets 
for the assay. One reaction for each sample was carried out to obtain genotyping results. 
HRM analysis used real-time PCR amplification of DNA samples. This allowed for the 
estimation of the quality of DNA templates taken to the reaction and prevented the 
inclusion of false results.
Both of these two methods were applied for genotyping adult mice and embryos at 13.5 
dpc. In these two groups the homozygous mutant Opal -/- genotype was not observed. 
This indicated lethality of Opal -/- embryos at the earlier stages of development (Davies 
et al., 2007).
Nnt mutation in the Opal colony was inherited from C57B1/6J parental strain. Nnt 
genotyping of the whole Opal colony had some impact on the progress of the 
experiments due to the priority need to first select animals that were Nnt mutation-free. It 
is still not known if this mutation (especially when homozygous) could modify the Opal 
+/- mouse phenotype, for example, the sensitivity to oxidative stress.
The long-term aim associated with Opal mouse breeding is to develop a congenic line by 
backcrossing to the C57B1/6J mouse. This will take a minimum of 10 generations (-2.5 
years). So far, during this study, animals of generation F5 have been bred, which are 
estimated to be approximately 94% congenic. The production of a congenic line may 
significantly influence the Opal mouse phenotype. It may smooth out the variability 
between animals and make the expression of the Opal mutation more obvious: the 
phenotype may become more or less severe.
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4. ANALYSIS OF MOUSE OPA1 TRANSCRIPTS
4.1 Introduction
The human OPA1 gene is composed of 31 exons of which 3 exons: 4, 4b and 5b are 
involved in alternative splicing. Alternative splicing results in the formation of 8 different 
OPA1 mRNA isoforms, which are ubiquitously expressed and show levels of expression 
specific to different tissues (Delletre et al., 2001; Olichon et al., 2007a; Introduction 
1.1.4.1) Interestingly, only one mutation has been reported so far in OPA1 alternative 
exons and this mutation is associated with partial recovery of visual loss (Comille at al., 
2008; Introduction 1.1.2).
The aim of this chapter was to characterize Opal transcription and alternative splicing in 
the mouse. The transcript profile was compared between retina and other tissues and was 
studied in the Opal heterozygous mutant and WT mice. Different Opal splice variants 
were amplified by RT-PCR using 3 primer pairs and their relative abundance in the retina 
was shown.
4.2 Characterization of mouse OPA1 mRNA isoforms
Mouse Opal mRNA isoforms were studied by RT-PCR. RNA was isolated from Opal 
+/+ and Opal +/- mouse tissues (retina, kidney, liver and spleen) and subjected to RT- 
PCR (Materials and Methods 2.8.2). PCR products were separated by electrophoresis on 
3.0-3.5% ethidium bromide stained agarose gel (Materials and Methods 2.4).
4.2.1 Primers design
To identify splice variants expressed in mouse tissues 3 different primer pairs were 
designed to full mouse OPA1 transcript (mOPAl) (Materials and Methods 2.6). The 
mOpal transcript variant containing 5b exon was taken from the Ensembl database 
(http://www.ensembl.org/Mus musculus) Gene: Opal (ENSMUSG00000038084). To 
identify exon 4b encoded by mOpal, human exon 4b was aligned to the genomic 
sequence of the mOpal gene and a BLAST search was used to confirm the presence of
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this sequence in the mouse cDNA library. Fig. 4.1 shows the primer sequences and their 
location in mOpal transcript (exons 1-9 are shown). The forward primer was identical for 
all three pairs.
Primer pair Sequence (5’-3’) Location
3F/8R forward
reverse
AAGTGGATTGTGCCTGACTTT
CAACCCGTGGTAGGTGATCT
exon 3 
exon 8/9
3F/5R forward
reverse
AAGTGGATTGTGCCTGACTTT
GCTCGAAATGCTGTTTCTCC
exon 3 
exon 5
3F/5bR forward
reverse
AAGTGGATTGTGCCTGACTTT
GCTTCTGTTGGGCATAGCTC
exon 3 
exon 5b
mOpal mRNA (exons 1-9)
3F 5R 5bR 8R
> ■ ■■ • t  « i  »t > > i  «
1 2 3 4  4b 5 5b 6 7 8 9
lOObp
Fig. 4.1 Primer sequences for mOpal transcript and schematic representation of an 
Opal mRNA fragment (1-9 exons) with marked primer binding sites (arrows).
Numbers below represent exons.
4.2.2 Identification of mOpal splicing variants in the retina
RT-PCR with a primer pair 3F/8R resulted in an amplification of 3 Opal fragments from 
retinal Opal +/+ and Opal +/- mouse samples. These fragments were postulated to be 
isoform 1 (478bp), isoform 7 (589bp) and isoform 8 (643bp), as described by Delettre et 
al (2001). Fig.4.2 depicts the relative abundance of these isoforms detected by ethidium 
bromide staining in a 3% agarose gel. Isoform 1 (without exons 4b and 5b) predominated. 
The longest isoform 8 was the full transcript containing all alternative exons: 4, 4b and 
5b. Isoform 7 was also detected corresponding to the fragment at the position of 589bp.
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500 bp—
600 bp-  
700 bp-
Opal +/+ +/- +/+ +/-
Fig. 4.2 Three Opal isoforms generated by alternative splicing were detected in the 
opal +/+ and opal +/- mouse retinas. Total RNA was extracted from mouse retinas and 
RT-PCR products were amplified using primer pair 3F/8R and analyzed on 3% agarose 
gel.
Next, the Opal transcript profile in mouse retina was explored by primer pairs 3F/5R and 
3F/5bR. All possible fragment sizes produced by alternative splicing of exons 4, 4b and 
5b were calculated for both PCR reactions and are presented in Table 4.1. Fragments of 
isoforms which did not contain exon 4 (279bp, 225bp, 134bp, 80bp) were not detected by 
RT-PCR and ethidium bromide staining in agarose gel (Fig. 4.3). In addition, the primer 
pair 3F/5R did not amplify an isoform containing exons 4 and 4b. With the primer pair 
3F/5bR it was possible to produce one band corresponding to the fragment of isoform 7 
(Ex4+Ex5b) or isoform 8 (Ex4+Ex4b+Ex5b).
Isoform 1 (Ex 4)
Isoform 7 (Ex 4,5b) 
Isoform 8 (Ex 4,4b,5b)
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Primer pair Exons Size Possibleisoforms
Ex4+Ex4b 242 5; 8
3F/5R Ex4 188 i;7Ex4b 134 3;6
No Ex4b and Ex4 80 2;4
Ex4+Ex4b+Ex5b 387 8
3F/5bR Ex4+Ex5b 333 7Ex4b+Ex5b 279 6
Ex5b 225 4
Table 4.1 Sizes of all possible fragments of mouse Opal transcripts generated by 
alternative splicing between exon 4, 4b and 5b.
3F/5bR
333/387bp
3F/5R
188bp
wt mut wt mut
Fig.4.3. Opal isoforms lacking exon 4 were not detected by RT-PCR in Opal +/+ and 
Opal +/- mouse retinas. Total RNA was extracted from mouse retinas and RT-PCR 
products amplified using primer pairs 3F/5R and 3F/5bR were analyzed on 3.5% agarose 
gel. Bands of the size 279bp, 225bp, 134bp and 80bp representing isoforms lacking exon 
4 were not detected. Also a band at the position 242bp, being the fragment amplified with 
exons: Ex4 and Ex4b, was not detected.
4.2.3 Transcription of mOpal in other mouse tissues
The Opal transcript profile was compared between retina and three other mouse tissues 
(kidney, spleen and liver). RT-PCR with a primer pair 3F/8R resulted in the identification 
of three isoforms in the retinal samples. In other tissues one additional isoform (isoform 
5: Ex4, 4b), which was not found in the retina, was also detected on Ethidium Bromide
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stained 3.5% agarose gel as a band in length of 532bp (Fig.4.4). The results indicate 
tissue-specific regulation of Opal transcription.
Opal Isoform 1 
Opal Isoform 5 
Opal Isoform 7 
Opal Isoform 8
K K R
Opal +/+ Opal +/-
Fig. 4.4 Four Opal splicing variants can be detected in mouse tissues.
RNA was isolated from kidney (K), spleen (S) and liver (L) of wild type and mutant mice 
at the age of 18 months. RT-PCR products amplified using primer pair 3F/8R were 
analyzed on 3.5% agarose gel. Samples were loaded in duplicate. R - Opal isoforms from 
the retina of 6 month old opal heterozygote.
4.3 Discussion
This work studied Opal transcription and alternative splicing in mouse tissues. In the 
retina of wild type and mutant mice three isoforms could be detected. The shortest 
isoform, which does not contain 4b and 5b alternative exons (isoform 1), is dominant, 
similarly to findings in the human retina (Delettre et al., 2001). Protein encoded by this 
variant was also found to be the most highly expressed isoform in the nervous tissue 
including retina (Akepati et al., 2008).
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We believe that two other isoforms found in the retina are isoform 7 (Ex4, 5b) and 
isoform 8 (Ex4, Ex4b, Ex5b). Such a profile has also been reported in HELA cells by 
Satoh et al., 2003. In order to verify this result DNA could be analyzed by sequencing. 
The presence of additional isoform 5 (Ex4, 4b) was detected in other mouse tissues (liver, 
kidney, spleen). The differences in the expression of Opal transcripts between retina and 
other tissues, especially the dominance of isoform 1 in the retina, suggest tissue- 
dependent regulation of Opal transcription. This needs further study in relation to ADOA 
and specific vulnerability of RGCs in this disease. Furthermore it is known that OPA1 
alternative exons 4b and 5b are involved in apoptotic process (Olichon et al., 2007a). 
Knowing that alternative splicing can be modified during apoptosis (Schwerk et al., 2005) 
there is a possibility worth studying that OPA1 alternative splicing is apoptotically- 
regulated.
In the experiments described in mouse tissues we were not able to detect isoforms which 
are produced by the alternative splicing of exon 4 and which are seen in human retina. 
This is in agreement with the data subsequently obtained by Akepati et al., 2008, who 
concluded that in the mouse only two exons (4b and 5b) are involved in alternative 
splicing. Interestingly, in invertebrates as in lower eukaryotes, no alternate splicing has 
been reported for OPA1 orthologe genes (Olichon et al., 2007a). This is clearly an 
example of how the genome evolved with increasing complexity to ensure more 
sophisticated regulation of cellular processes.
Recently it has been shown that the majority of OPA1 mutations that lead to a premature 
termination codon (PTC) results in reduction of OPA1 transcript level in the cell by the 
mechanism known as nonsense-mediated mRNA decay (NMD) (Schimpf et al., 2008). 
NMD is the process triggered by ribosome to degrade aberrant mRNAs (Amrani et al., 
2006). The Opal mouse mutation causes the premature termination of translation 
(Introduction 1.4.2) and therefore it is likely to stimulate NMD pathway. Our qualitative 
RT-PCR analysis showed that the three Opal isoforms found in wild type mouse retina 
were also expressed in mutant mice. Performing quantitative RT-PCR in the future would 
determine the level of their expression.
81
5. RETINAL DEGENERATION IN 
OPA1 +/- MOUSE MODEL
Chapter 5 Retinal degeneration in O pal +/- mouse model
5. RETINAL DEGENERATION IN OPA1 +/- MOUSE MODEL
S.l Introduction
The ADOA disease phenotype is characterized by RGC death and optic nerve 
degeneration (Johnston et al. 1979; Kjer et al., 1983; Introduction 1.1.1). Johnson et al. 
and Kjer et al. both reported that there was a significant reduction in RGCs in aged 
ADOA patients on retinal histology. In addition, we see evidence for RGC loss in patients 
with ADOA as evidenced by reduced PERG on electrophysiology (Beminger et al., 1991; 
Holder et al., 1998). The generation of Opal mouse models allows the study of the 
mechanism of cell death in ADOA. At the young age of 6 months Opal heterozygous 
mice do not lose cells in their retinal ganglion cell layer when assessed by counting nuclei 
in retinal sections (Davies et al., 2007; Introduction 1.4.2). However, in another Opal 
mouse model with a splice site mutation that causes a skipping of exon 10 RGC loss has 
been observed and the cell loss was time-dependent. The experiments were done on 
whole mount retinal preparations with retrograde labelled RGCs from mice at the age of 2 
to 13 months (Alavi et al., 2007; Introduction 1.4.3).
In this chapter RGC loss was studied in aging mice. RGCs were quantified in retinal 
sections from 24-month old heterozygous and WT mice. Additionally TUNEL assay was 
used to test whether an increase in apoptosis could be detected.
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5.2 Quantification of RGCs and the retinal thickness in aged animals
Retinal cross sections of 24-month old Opal +/+ and Opal +/- mice (n=5) were mounted 
and stained with H&E (by Vanessa Davies). Counts of cells in retinal sections were 
carried out manually by counting all nuclei in the RGC layer (Materials and Methods 
2.13). The results do not show a significant reduction in the number of cells in the RGC 
layer in mutant mice (Table 5.1). Overall retinal thickness was compared between wild 
type and heterozygote mice (n=5) in the same retinal cross sections with the 
measurements taken across the thickest region of the retina (Materials and Methods 2.13). 
No difference was found between the two genotypes (Table 5.1).
Genotype mean of total score ± SEM mean of retinal thickness ± SEM [pm]
Opal +/+ 4831±552 277±26.4
Opal +/- 5513±664 287.6±14.9
Table 5.1 Mean total score of cell counts in RGC layers and retinal thickness of 24- 
month old opal +/+ and Opal +/- mice. Data are presented as means of total score 
±SEM of 5 animals for each genotype. The difference in the cell number and retinal 
thickness between groups was analyzed using unpaired Student’s /-test and was not 
statistically significant.
However, there are a number of methodological problems with the original data set that 
may preclude further, meaningful and statistically significant analysis. Firstly, it needs to 
be emphasized that the raw data obtained showed a high distribution, which suggests that 
if there was any difference in the retinal thickness between wild type and mutant mice, it 
could be difficult to demonstrate. The most significant error in the measurements was 
derived from the comparison of the retinal thicknesses averaged from five different 
regions in each eye. This error is important due to the fact that the retinal thickness is not 
constant and varies with retinal eccentricity. Secondly, the eyes were fixed and embedded 
in a number of orientations, and hence sectioning is not consistently on the same axis. 
This makes comparison between eyes difficult. Thirdly, it is not possible to identify the 
optic nerve for orientation in the sections, to enable a positional ‘like for like’ approach.
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Due to the lack of available animal resources the experiment could not be repeated with a 
new protocol. There are very few aged animals in the colony and it is not feasible to wait 
another 12 months for ageing of subjects. Were it to be possible, new histological 
sections of the retinas would be collected and equivalent sections of the retinas would be 
compared: all the eyes would be sectioned in the same plane and the retina would be 
measured in the same region marked by the presence of the optic nerve.
5.3 Apoptosis is not observed in the Opal +/- RGC layer in old animals
Apoptosis was studied in the retinal sections of 24 month old animals (3 heterozygotes 
and 3 controls) by TUNEL assay (Materials and Methods 2.14). No TUNEL-positive 
cells were seen in the mutant RGC layers, or in the WT (Fig.5.1) but staining was 
observed in the positive control.
Fig.5.1 Representative retinal sections from 2 year old animals labelled for TUNEL
(A) Negative control sections without incubation with TdT enzyme
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(B) Positive control section treated with DNase to induce DNA cleavage (for better 
presentation of fluorescein signal nuclei staining is omitted)
(C) Wild type and (D) mutant retinal sections demonstrate negative-labelling for 
TUNEL (fluorescein labelling) in the RGC layer (RGC). Nuclei were stained with 
Hoechst 33342. Pictures were taken with Leica DM6000B microscope equipped 
with CFC350FX camera and LAS AF6000 software under fluorescein and DAPI 
filters. Bar= 100pm
5.4 Discussion
Degeneration in the Opal +/- mouse model
In Opal +/- aging mice we were unable to find an increased rate of cell death and detect 
apoptosis in the RGC layer. The images showed similar density of cells in the RGC layer 
in mutant and control mice and the number of cells counted was not significantly 
different. Although cell loss and active evidence of apoptosis was not detected other 
research using electron microscopy identified prominent degenerative changes in our 
mutant mouse line RGCs and optic nerves. In particular, an increased autophagy was 
observed in 24 month old mutant mice and it is postulated that it could be one mechanism 
contributing to RGC loss in ADOA (White et al., 2009). An increased autophagy in the 
Opal mouse model could be primarily caused by impaired mitochondrial fusion, which 
could result in accumulation of defective mitochondria (Vicencio et al., 2008, White et 
al., 2009). Apart from the presence of more autophagosomes in mutant mice 
mitochondrial cristae abnormalities and demyelination of the optic nerve were also found 
(see also Introduction 1.4.2).
Mouse model of human disease
How well does the Opal mouse model represent ADOA disease? The cell loss in the 
retinal ganglion cell layer, which is the major feature of ADOA disease, was not observed 
in mutant mice. However ADOA disease is characterized by its high variability of clinical 
expression with some patients being asymptomatic and others developing a severe visual 
impairment over time (Votruba et al., 2003). Performing the study on a larger number of 
mice could possibly reveal more affected animals.
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There is evidence that visual function can be impaired in Opal heterozygous mice 
(Davies et al., 2007). In the mutant Opal+I- mice aged 12 months a significant reduction 
in OKN responses was reported suggesting that there must be some compromise to RGC 
or optic nerve functions. Furthermore it has been demonstrated with electron microscopy 
that morphological abnormalities were visible by 9 months of age in RGC axons and 
along the nerve fibre bundles in mutant mice (Davies et al., 2007). Therefore it is possible 
that we observe primarily axonal pathology occurring before RGC loss. A similar 
mechanism of degeneration has been also described in the DBA/2 mouse model of 
glaucoma (Buckingham et al., 2008).
A limitation of the current method was that the RGC count was performed on retinal 
sections. In addition to RGCs, the RGC layer is comprised of approximately equal 
numbers of displaced amacrine cells (Jeon et al., 1998). This made the observation of 
decrease in the number of RGCs alone difficult to detect. Supposing that the cell death 
proceeds in Opal +/- mutant mice at the slow rate, it would still be very unlikely that we 
could capture some cells undergoing apoptosis at the same time in retinal sections. 
Therefore the fact that we could not see apoptosis does not argue against the possibility of 
the slow cell death. It is also important to bear in mind that mice lack macula, the area 
which is primarily affected in ADOA disease, and we do not know how this difference 
can be significant in our study.
To summarize retinal histological analysis in 24 month old mutant Opal +/- mice did not 
show any significant reduction in the cell count in retinal sections. The process of RGC 
degeneration could be further studied using other techniques such as: optic nerve axon 
counts, quantification of immunolabelled (or retrograde labelled) RGC on whole mount 
retinas or the analysis of expression of RGC-specific genes.
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6. OPA1 PROTEOLYSIS IN MITOCHONDRIA AND MITOCHONDRIAL 
MEMBRANE POTENTIAL IN OPA1 +/- MOUSE MODEL
6.1 Introduction
Although a role for OPA1 protein in mitochondria has been proposed (see Introduction 
1.2.4-1.2.6) the pathological mechanism developing in ADOA disease is still unknown. 
Amongst possible causal factors considered are: bioenergetic failure, mitochondrial 
network and distribution abnormalities and increased apoptosis (Lodi et al., 2004; Amati- 
Bonneau et al., 2005; Spinazzi et al., 2008; Zanna et al., 2008).
In this chapter Opal +/- mice have been used for the study of correlation between the 
level of Opal in the mitochondria and the polarization of the mitochondrial inner 
membrane. Many studies have highlighted the link between Opal function and the 
mitochondrial membrane potential. Firstly, Opal contributes to the formation of the 
mitochondrial network in a cell by controlling mitochondrial fusion, which strictly 
depends on the intact mitochondrial membrane potential (Meeusen et al., 2004). 
Secondly, Opal knockdown by siRNA has been shown to cause a dramatic drop in the 
mitochondrial membrane potential in cells (Olichon et al., 2002; Olichon et al., 2007a). 
Thirdly, Opal is known to be an antiapoptotic protein and the role of Opal protein in 
reducing the loss of mitochondrial membrane potential during apoptosis has been 
proposed (Frezza et al., 2006). Here, the experiment was performed to confirm a 
diminished mitochondrial level of Opal in Opal +/- mutant mice followed by the 
measurement of an average mitochondrial membrane potential in the retina.
Human and mouse Opal protein exists in several isoforms of different length that have 
been categorized as long and short isoforms (Introduction 1.2.2). It has been 
demonstrated that dissipation of the mitochondrial membrane potential stimulates 
proteolysis of long isoforms culminating in the accumulation of short isoforms (Ishihara 
et al., 2006; Griparic et al., 2007; Guillery et al., 2008). Opal processing has been 
reported in some mitochondrial diseases and in mouse models where mitochondrial 
dysfunction has resulted in bioenergetic crisis (Duvezin-Caubet et al., 2006). To shed 
more light on mitochondrial dysfunction in ADOA disease Opal processing has been 
studied in Opal +/- mice by analysis of the relative expression of long versus short Opal 
isoforms.
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To summarise, these experiments centre on proteolysis of Opal in mitochondria and 
mitochondrial membrane potential and it is proposed that this can indirectly indicate a 
bioenergetic competence of mitochondria in heterozygous Opal mice.
6.2 Opal deficient mouse {Opal +/-) has a reduced level of Opal protein isoforms in 
mitochondria.
Comparison of Opal isoform expression in mitochondria of Opal +/- mice to Opal +/+ 
mice was made by western blot (Materials and Methods 2.12). Mitochondria were 
isolated from the retina and proximal part of the optic nerve of 9 animals of each 
genotype (Materials and Methods 2.9) and tissue samples from 3 animals were pooled. 
For data normalization cytochrome c was selected initially (6.2.1), but was later replaced 
by Hsp60 (6.2.2).
6.2.1 Western blot for cytochrome c on mitochondria isolated from mouse
brain.
Originally for Opal quantification on the blot, cytochrome c was selected to control for 
variation in mitochondrial protein. The Western blot for cytochrome c was optimized on 
mitochondria isolated from brain tissue from two different Opal+/+ mice and the 
representative blot from these two mitochondrial samples (mitl and mit2 in Fig.6.1) 
shows bands specific to cytochrome c.
Opal +/+ Opal +/+  
mitl mitl mit2 mit2
15kDa ~ * —  —
Fig.6.1 Western blot for cytochrome c (15kDa) on isolated mitochondria from brain.
Mitochondria were isolated from Opal +/+ mouse brain (Materials and Methods 2.9).
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Fig.6.1 (continued) Mitochondrial proteins from two animals were loaded in duplicate 
onto SDS-polyacrylamide gel. SDS-PAGE electrophoresis was followed by blotting to 
nitrocellulose and cytochrome c antibody binding. The cytochrome c bands show the 
position of approximately 15kDa in the mitochondrial fraction.
Later cytochrome c was replaced by the mitochondrial molecular chaperone Hsp60 
because of its larger molecular weight (~60kDa). In order to achieve better resolution of 
Opal various isoforms on the blot, SDS-polyacrylamide electrophoresis was extended 
until protein marker approximately 50kDa reached the bottom of the gel. Proteins of 
lower molecular weight including cytochrome c were lost from the gel.
6.2.2 Western blot for Opal on mitochondrial proteins from the retina and 
optic nerve. Calculation of relative expression of long versus short opal isoforms
Opal immunoblot revealed a reduction of Opal protein isoforms in mitochondria of 
Opal +/- mice as compared to control group (Opal +/+ mice) (Fig.6.2). This reduction 
was similar for both long and short isoforms, because the mean ratio: expression of long 
versus short isoforms was comparable in both genotypes (0.83 and 0.87 for Opal +/+ and 
Opal +/- respectively) (Fig.6.3).
The results showed that the mitochondrial Opal level was significantly reduced in Opal 
+/- mice. However an increased proteolysis of long Opal isoforms, which could be 
triggered by the loss of mitochondrial membrane potential, was not observed in mutant 
mice.
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A
Opal +/+ Opal +/-
lOOkDa ► mmmmm -  mmmmrn ■ ■■ — »   long Opal isofoims
80kDa —► M i  M M  mmmm mmamm mmmm mamma —  short Opal isoforms
  ~    Hsp60
B
Opal mitochondrial expression  
in the retina and optic nerve of opal m ouse
1.4 -
long opal isoforms short opal isoforms
Fig.6.2 Western blot for Opal on isolated mitochondria from retina and proximal 
part of optic nerve.
A. Mitochondria were isolated from the retina and optic nerve of nine animals (3 animals 
per pool) and Western for Opal was performed. 20 pg of mitochondrial protein extract 
was separated in 8% SDS-PAGE followed by blotting to nitrocellulose and antibody 
binding. B. Opal expression in Opal +/+ and Opal +/- mice was measured by 
densitometry analysis o f Opal bands. Opal band intensities were normalized to the 
Hsp60 signal from the same mitochondrial samples. The results are presented as mean ± 
SD of 3 independent samples and are expressed as fraction of the Opal +/+ control.
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Asterisk indicates statistical significance (p < 0.05) versus the respective Opal +/+ group 
(two-tailed unpaired t test) obtained for short isoforms.
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opal +/+ opal +/-
Relative expression of long
versus short isoforms
Opal mean SEM
+/+ 0.83 0.21
+/- 0.87 0.04
Fig.6.3 Pattern of Opal isoforms is not altered in Opal mutant mouse.
Western blot analysis o f the ratio: expression of long versus short isoforms for 3 separate 
Opal +/+ and Opal +/- samples (data are presented as fraction of 1 for one Opal +/+ 
sample). The mean relative expression o f long versus short isoforms is similar in both 
genotypes
6.2.3. The effect of CCCP on Opal proteolysis studied in MEFs by Western blot
To rule out the possibility that the lack o f Opal proteolysis found in the mitochondria of 
mutant mice was due to the limitations o f the method, Western blot was performed on 
MEFs isolated from Opal +/+ 13.5 days post coitum (dpc) embryos (Materials and 
Methods 2.11) treated with carbonylcyanide w-chlorophenyl hydrazone (CCCP). CCCP 
is an uncoupling agent that disperses the mitochondrial membrane potential and has been 
recently shown to enhance the processing o f O pal, leading to the accumulation of short 
isoforms (Duvezin-Caubet et al., 2006; Ishihara et al., 2006). Opal +/+ MEFs were 
treated with CCCP at two doses 10 and 20 pM for 16 hours and Western blot for Opal 
was performed on cells treated with CCCP and the control cells (not treated with CCCP) 
(Fig.6.4) (Materials and Methods 2.12). The blot showed the expression of five Opal 
isoforms in control cells. These isoforms are the products of translation of mRNA spliced 
isoforms and their posttranslational proteolytic processing at the S1 and S2 sites (Song et
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al., 2007). The blot also shows CCCP-induced degradation of the long Opal isoforms 
(~100kDa MW) and accumulation o f the short isoforms (~80kDa MW). Therefore, by 
using CCCP to induce dissipation o f the mitochondrial membrane potential it was 
possible to observe Opal proteolysis on the immunoblot. The fact that Opal proteolysis 
was not found in Opal +/- mice could not be to due to the limitations of the method.
16 h CCCP 10 pM 20 pM
+ - +
lOOkDa
80kDa
actin
Fig.6.4 Western blot on Opal +/+ MEFs showing accumulation of short Opal 
isoforms after 16 hours treatment with CCCP.
MEFs were treated with CCCP at concentrations o f 10 and 20 pM for 16 hours. Both 
doses caused proteolysis o f two Opal long isoforms that resulted in the lack o f detectable 
Opal bands at the position o f MW~100kDa. In the control samples five Opal isoforms 
including these degraded in CCCP-treated MEFs were observed. CCCP treatment in both 
doses induced the accumulation o f the shortest isoforms at the position of MW~80kDa. 
Actin was used as a loading control.
6.3 Mitochondrial membrane potential in retina and brain of Opal +/- mouse is not 
changed
6.3.1 A\j/ assessment in retina and brain using JC-1 dye
JC-1 fluorescence is sensitive to changes in mitochondrial membrane potential (A\|/).
In healthy polarized mitochondria the dye forms red fluorescent aggregates in 
mitochondria (fluorescence at 595nm), and the dissipation of membrane potential reduces 
red fluorescence proportionally to the change in (A\|/) (and increases green fluorescence 
of JC-1 monomers causing a shift in the emission spectrum from red to green colour).
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To investigate if there is a difference in the average mitochondrial membrane potential 
between Opal +/+ and Opal +/- animals, mitochondria were isolated from retina and 
brain tissue (Materials and Methods 2.9) and membrane potential was assessed in isolated 
mitochondria by spectrofluorimeter analysis of JC-1 red fluorescence (Materials and 
Methods 2.15). The same concentration of mitochondria 25 pg/ml was used for the assay. 
The results did not show any statistically significant difference in Opal +/- average 
membrane potential in the retina and brain when compared to Opal +/+ mice (p>0.05, 
unpaired T-Test) (Fig.6.5). For control the mitochondrial membrane potential was 
measured in four samples (two Opal +/+ and two Opal +/- samples) two minutes after 
addition of CCCP (InMmg'1 proteins). In all samples the membrane potential dropped to 
approximately 30% of original values (mean=33.875, SD=4.66).
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Fig.6.5 Mitochondrial membrane potential in the retina and brain of Opal +/- mouse 
is not changed. (A) Mitochondria were isolated from the retina (n=3, 6 retinas per 
sample) and brain (n=3) o f Opal +/+ and Opal +/- animals. Mitochondrial membrane 
potential was measured in Opal +/+ and Opal +/- samples by spectrofluorimeter analysis 
of JC-1 dye fluorescence at 595nm. The excitation wavelength was set at 490nm. The 
difference in JC1 fluorescence was not statistically significant in the Opal +/- animals as 
compared to Opal +/+ mice (p>0.05, T-test) in both brain and retina samples. (Data 
represent mean ± SD of 3 different samples and are expressed as % of Opal +/+).
(B) Respective spectra o f JC1 fluorescence in the retina and brain show the peak of the 
fluorescence at the approximately 590nm.
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6.4 Discussion
The main aim of this chapter was to evaluate mitochondrial membrane potential in the 
retinas from Opal +/- mutant mice.
First Western blot confirmed diminished expression of Opal protein in the mitochondria 
isolated from the retinas. The expression was about half of that detected in the wild type 
mice. However, despite this change reduction in mitochondrial membrane potential was 
not observed.
Opal proteolysis and mitochondrial membrane potential in the retina of Opal +/- 
mice
It is known that the loss of mitochondrial membrane potential triggers proteolysis of 
Opal in the inner membrane. This has been reported in some mitochondrial diseases such 
as MERRF (Myoclonic epilepsy associated with ragged-red fibers) and MELAS 
(Mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes) 
and in mouse models with the impaired mitochondrial biogenesis (Duvezin-Caubet et al., 
2006). The experiments presented here showed consistently that in Opal +/- mice with 
normal mitochondrial membrane potential there was no increased proteolysis of Opal 
protein.
Opal proteolysis- role in mitochondrial homeostasis and apoptosis
A few proteases, which may act cooperatively, have been linked to Opal processing. 
Opal processing has been shown to be stimulated by ATP- dependent mAAA proteases, 
Ymel and PARL (Cipolat et al., 2006; Duvezin- Caubet et al., 2006; Frezza et al., 2006; 
Ishihara et al., 2006; Song et al 2007). There is a distinction between a constitutive 
cleavage and an inducible cleavage of Opal with different proteases suspected to be 
implicated in these processes (Griparic et al., 2007). The constitutive cleavage is the 
physiological process that enables Opal protein to perform fusion, whereas inducible 
cleavage is triggered by the dissipation of mitochondrial membrane potential and 
probably inactivates Opal protein. The molecular mechanism for Opal inducible 
cleavage has not been fully described yet. Recently theory has developed that presents it 
as a mechanism which supports mitochondrial homeostasis. According to this proteolysis 
of long Opal isoforms is associated with mitochondrial fragmentation. As a result of this 
dysfunctional and energetically compromised mitochondria become segregated from the
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intact tubular network, which reduces further propagation of the damage (Duvezin- 
Caubet et al., 2006).
Interestingly, a study on Opal protein isoforms in mice showed that the Opal band 
pattern is identical in neuronal tissues, like brain, retina and astrocytes but differed from 
the pattern expressed in other tissues (Akepati et al., 2008). The major difference was in 
the predominance of Opal isoform 1 in the nervous system. Because this isoform has 
been shown to increase the elongation of mitochondria and to prevent cells from 
apoptosis (Frezza et al., 2006), the authors believe that mutations affecting this isoform 
may have a strong impact especially on neurons. They also point out that all mutations 
found in ADOA patients reside in the exons present in the isoform 1 transcript suggesting 
the link between the level of functional isoform 1 and RGCs survival.
Mitochondrial membrane potential in optic nerve diseases
So far in optic atrophy diseases membrane potential reduction has been associated with 
oxidative stress. Battisti et al studied the effect of dRib- induced oxidative stress on 
mitochondrial membrane potential in LHON. The JC-1 test revealed greater 
depolarization of the mitochondrial membrane potential in lymphocytes from patients, 
with a percentage of cells emitting green fluorescence being 91.6% in LHON and 75.7% 
in the control. There was also an increased rate of apoptosis in LHON lymphocytes 
(Battisti et al., 2004) {Opal +/- embryonic fibroblasts vulnerability to oxidative stress is 
discussed in Chapter 7). The link between oxidative stress, membrane potential reduction 
and optic nerve degeneration was also shown in ribozyme-induced SOD2 knockdown 
mouse. While a mutant mouse showed loss of RGCs and loss of axons and myelin in the 
optic nerve, infection of NIH/3T3 cells with this ribozyme caused a 64% reduction in 
mitochondrial membrane potential. (Qi et al., 2003).
Concluding remarks
Opal +/- mutant mice show the late onset of the disease that affects their visual 
performance. The disease is slowly progressive with structural abnormalities developing 
in the mitochondria from the RGC layer and the optic nerve (Davies et al., 2007; White et 
al., 2009). This study was carried out on young animals which performed well in visual 
tests and therefore was aimed at finding early molecular changes in mitochondrial 
function that could cause the disease. The results suggest that other factors than 
destabilization of mitochondrial membrane potential may be responsible for the
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development of the disease in Opal +/- mutant mice. However it is possible that the 
measurements of mitochondrial membrane potential should target more specifically 
mitochondria from the RGC layer and the optic nerve because the change measured in the 
whole retina is too modest and under the sensitivity threshold of the assay. Mitochondrial 
membrane potential could be measured in RGCs isolated from the mouse retina by 
immunopanning or laser cupture microdissection. It would be also interesting to compare 
this with the study of mitochondrial membrane potential in older Opal +/- mice which 
develop pathological changes in the structure of their mitochondria.
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7. MITOCHONDRIAL MORPHOLOGY AND VULNERABILITY TO 
OXIDATIVE STRESS IN OPA1 +/- MOUSE MODEL
7.1 Introduction
The aim of the experiments described in this Chapter was to seek more evidence that 
could suggest to what extent Opal mutation in Opal +/- mice could be pathological for 
the mitochondria and the cell. Opal protein is required for mitochondrial fusion, a 
process that plays an important role in the biology of the cell and a protective role in 
apoptosis (Frezza et al., 2006). Fusion-defective cells have reduced growth rates, reduced 
respiration and a mitochondrial population prone to loss of mitochondrial membrane 
potential (Chen et al., 2005). When fusion is inhibited, unopposed fission leads to 
mitochondrial fragmentation (Chen et al., 2003). Opal is also involved in maintaining 
cristae structure and Opal knockdown by siRNA leads to disorganized cristae (Griparic 
et al., 2004, Amoult et al., 2005). It has recently been shown that impaired Opal function 
in mitochondria due to prohibitin deficiency results in an impaired cell proliferation 
(Merkwirth et al., 2008). Furthermore, an alteration in mitochondrial morphology also 
accompanies a cellular response to oxidative stress (Jendrach et al., 2008, Koopman et al.,
2005).
The appearance of alterations in mitochondrial morphology in Opal +/- mice, cell vitality 
and resistance to oxidative stress were studied. Gene expression analysis in the retina was 
performed to cast light on key genes implicated in mitochondrial structure which might 
be altered in their expression. Imaging of mitochondrial morphology was carried out in 
Opal +/+ and Opal +/- MEFs. Cell growth was assessed by the population doubling 
level and the vulnerability of Opal+I- MEFs to oxidative stress was studied with 
hydrogen peroxide and blue light treatment.
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7.2 Expression of selected genes in the retina that regulate mitochondrial 
morphology is normal in 3 month old Opal +/- mice
7.2.1 Selection of genes for qRT-PCR
Mitochondrial morphology in the retina of Opal +/- mouse was studied by preliminary 
analysis of the expression of six genes by qRT-PCR (Materials and Methods 2.8.3). The 
selection of genes was based on two objectives: to explore whether reduction of Opal in 
mitochondria activates other genes that are known to shape the mitochondrial network 
and second, to learn whether the IMM structure is normal in mutant mice. The list of 
genes included Spg7, Mfn2 and Dnmll, which were classified in Gene Ontology to 
biological process involved in mitochondrial organization (Table 7.1). It has been shown 
that Spg7 regulates Opal processing and Spg7 knockdown induces highly connected 
mitochondrial network (Ishihara et al., 2006), Mfn2 promotes mitochondrial fusion (Chen 
et al., 2003), whereas Dnmll promotes fission. In addition, Dnmll together with its 
interacting partner Bik induces cristae remodelling. During apoptosis Bik stimulates 
opening of the cristae junctions, which mobilizes cytochrome c for the release (Germain 
et al., 2005). Therefore it has been assumed that the change in the transcription of Dnmll 
and/or Bik may conceivably suggest the alteration in cristae organization. Two last genes 
that were studied: Slc25a4 and Atp5k while being directly involved in energy metabolism 
(Table 7.1) are also important structural and functional components of the inner 
mitochondrial membrane. Inhibitors of Slc25a4 have been shown to induce a dramatic 
change in inner membrane topology in beef heart mitochondria (Scherer et al., 1974). 
Moreover Slc25a4 (ANTI- adenine nucleotide translocator) regulates the activity of 
permeability transition pores and through this cell death (Vieira et al., 2000; Kokoszka et 
al., 2004). Mutations in Slc25a4 are responsible for another eye disease Autosomal 
Dominant Progressive External Ophthalmoplegia (OMIM 609283). Atp5k (subunit e of 
ATP synthase) contributes to the correct curvature of the inner membrane (cristae 
formation) (Paumard et al., 2002; Gavin et al., 2004). Studies on Saccharomyces 
cerevisiae have shown that the stability of subunit e is regulated by Mgml (yeast 
homolog of opal) (Amutha et al., 2004).
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Gene Go Term (GO ID)
Mfn2
Spg7
Dnmll
Bik
Slc25a4
Atp5k
Mitochondrial fusion (0008053)
Mitochondrion organization (0007005)
Mitochondrial membrane organization (0007006) 
Induction of apoptosis (0006917)
Generation of precursor metabolites and energy (0006091) 
ATP synthesis coupled proton transport (0015986)
Table 7.1 Functional classification of genes selected for qPCR by Gene Ontology 
(http://www.geneontology.org/). Go Category: biological process.
Primers for all experimental genes and the chosen housekeeper gene for data 
normalization (Hprt) were designed using Primer3 software (Materials and Methods 2.6; 
2.6.1). Specificity of the primers to the respective mouse transcripts was verified by 
determining PCR amplicon sizes in 2% agarose gel electrophoresis (Fig.7.1) and melting 
curve analysis (Fig.7.2) (Materials and Methods 2.4; 2.6.2). PCR amplification was 
performed on randomly selected Opal +/+ and Opal +/- retinal samples.
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200bp
Mfn Dnm Bik Atp Sic Spg
B
Hprt (198bp)
Gene Length (bp)
Mfn2 219
Dnmll 238
Bik 229
Atp5k 176
Slc25a4 184
Spg7 194
Fig.7.1 Specificity of the primers verified by analysis of PCR products on 2% 
agarose gel. Specificity of the primers designed for each gene was verified by 
comparison of the amplicon sizes separated by 2% agarose gel electrophoresis to the 
theoretical calculations. There were no non-specific amplification products. (A) 
Fragments of genes PCR-amplified from mouse retina were stained with Ethidium 
Bromide and observed under UV light. Bands in the ladder show increasing length every 
lOObp. (B) Theoretical calculations of all fragments are based on the knowledge of 
mRNA sequences and primer recognition sites in the mRNAs.
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Fig.7.2 Specificity of the primers verified by melting curve analysis.
Primers were designed for six genes. For each gene 3-4 different cDNA samples run in 
duplicate were PCR amplified and their melting curves analyzed. Single melting curves 
indicated purity of the products.
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7.2.2 Quantification and quality of RNA samples
RNA was isolated from the retinas o f 3 month-old mutant and wild type mice (Materials 
and Methods 2.7.1) and was quantified by staining with RiboGreen Reagent and reading 
the fluorescence of RiboGreen bound to RNA (Materials and Methods 2 .1 2 2 , Appendix 
2).
RNA integrity of all retinal samples was assessed by the intensity of specific ribosomal 
RNA bands: 28S rRNA and 18S rRNA after denaturing agarose gel electrophoresis 
(Fig.7.3) (Materials and Methods 2.5).
28S rRNA 
18S rRNA
Fig.7.3 Denaturing agarose gel electrophoresis of RNA samples.
To check the integrity o f RNA isolated from mouse retina, 20 RNA samples from Opal 
+/+ and Opal +/- animals (Appendix 2) were separated by denaturing agarose gel 
electrophoresis. Two distinct bands specific for 28S rRNA and 18S rRNA were detected 
in all RNA samples.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
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7.2.3 Analysis of gene expression by two step qRT-PCR
The expression of genes involved in mitochondrial morphology in retina of Opal +/- 
mice was quantified by the two step relative qRT-PCR method and was compared to the 
expression levels in Opal +/+ mice. The relative expression of each gene was determined 
by the AACt method (Materials and Methods 2.8.3). The reference gene Hprt was used to 
control for variation in cDNA amount. (Hprt expression was reported stable in the models 
of pathological RGC death (Agudo et al., 2008)). Standard curves were run for both the 
target and reference gene in each assay and the coefficient determination obtained was R 
>0.98 (Fig.7.4). Amplification efficiencies (E) generated from standard dilution curves 
were compared between the target gene and Hprt. The difference in efficiency was for 
Spg7, Bik, Slc25a4, Atp5k: AE<0.04. For Mfn2 and Dnmll AE was 0.13 and 0.17 
respectively.
Mfn2- Mitofusin 2
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403525 3020155 10
Spg7- spastic paraplegia 7 homolog
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Fig.7.4 Amplification standard curves for all genes (continued on the next page).
Amplification curves were the products of 40 cycles of real-time PCR amplification of 
cDNA template using gene-specific primers. cDNA template was prepared from 
randomly selected Opal samples. cDNA samples prepared in four standard dilutions
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were run in duplicate for each assay. Conditions for PCR amplifications are described in 
details in Materials and Methods 2.8.3.
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Bik-Bcl2- interacting killer
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Fig.7.4 Amplification standard curves for all genes (continued from the next page).
Amplification curves were the products of 40 cycles real-time PCR amplification of 
cDNA template using gene-specific primers. cDNA template was prepared from 
randomly selected Opal samples. cDNA samples prepared in four standard dilutions
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were run in duplicate for each assay. Conditions for PCR amplifications are described in 
details in Materials and Methods 2.8.3.
Statistical analysis o f qRT-PCR results from six animals per group was done by T-Test 
for independent samples. In each assay samples were run in duplicate and the obtained 
intra-sample variation was SD< 0.65%. The difference in the expression of six candidate 
genes in Opal +/- mouse retina was not found statistically significant when compared to 
Opal +/+ animals (p>0.05) Data represent mean± SD of six animals (Fig.7.5).
□ wt
□ mutant
Spg7 Mfn2 Dnmll Slc25a4 Atp5k BIK
qRT-PCR analysis of gene expression in retina, mean±SD
gene Spg7 Mfn2 Dnmll Slc25a4 Atp5k Bik
Opal +/+ 1±0.09 1±0.08 1±0.07 1±0.09 1± 0.195 1±0.21
Opal +/- 1.08±0.15 1±0.025 0.94±0.09 1.07±0.10 0.925±0.05 0.91±0.27
Fig.7.5 Expression of genes involved in mitochondrial morphology in retina is not 
changed in 3 month-old Opal mutant mice
Six candidate genes were studied by qRT-PCR. Results are presented as fold change of 
average expression level for Opal +/- and Opal +/+ animals ± SD. Statistical 
significance was determined by unpaired t-test. Mean fold change in the expression of
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genes from mutant retina was not significantly different when compared to wild type 
mice, p>0.05.
7.3 Comparative analysis of mitochondrial morphology in Opal +/+ and Opal +/- 
MEFs
7.3.1 Classification of mitochondrial morphology in MEFs
To compare mitochondrial morphology in Opal +/+ and Opal +/- MEFs, cells were 
isolated from 13.5 dpc embryos and stained with Mitotracker Red (Materials and 
Methods 2.16; 2.17). Mitochondrial morphology was classified into three categories 
which differed in the average length of mitochondrial particles measured in the 
mitochondrial network (Materials and Methods 2.18): tubular category had an average 
particle length > 2pm, intermediate was in the range l-2pm and fragmented < 1pm. 
Fig.7.7 presents three representative pictures o f MEFs belonging to these categories 
found in Opal +/+ and Opal +/- lines. Table 7.2 presents the mean particle length and 
standard deviation obtained for each category in Opal +/+ and Opal +/- MEFs with 
measurements comparable in both groups. Mitochondrial particles were measured in 73 
and 97 Opal +/+ and Opal +/- cells respectively. For control Opal +/+ and Opal +/- 
MEFs were treated with ImM H2O2 for lh, which induced extensive mitochondrial 
fragmentation in all cells (Fig.7.6). The average length of mitochondrial particles was 0,4 
pm, SD =0,01.
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Fig.7.6 The representative fluorescent image of OPA1 +/+ MEF treated with ImM 
H2O2 shows fragmentation of mitochondrial network (stained with Mitotracker Red).
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Fig.7.7 Mitochondrial morphology. Fluorescent images of three classes of 
mitochondrial morphology. Mitochondria were stained with Mitotracker Red and 
mitochondrial morphology was divided into three categories: tubular (A), intermediate 
(B) and fragmented (C). Bar =20pm.
Mitochondrial particles, mean length ±SD [pm]
Cells Tubular Intermediate Fragmented
Opal +/+ 
(n= 73) 2.39±0.27 1.53±0.27 0.93±0.06
Opal +/- 
(n= 97) 2.28 ±0.22 1.47±0.25 0.88±0.08
Table 7.2 Classification of mitochondrial morphology in MEFs. The mean length±SD 
of mitochondrial particles was obtained for tubular, intermediate and fragmented network 
in Opal +/+ and Opal +/- MEFs. On average 25-50 particles per cell were measured in 
73 Opal +/+ and 97 Opal +/- MEFs.
7.3.2 Quantification of mitochondrial morphology in Opal +/+ and Opal +/-
MEFs
The percentage of Opal +/+ and Opal +/- cells with selected mitochondrial morphology 
was quantified and is presented in Fig. 7.8. The results are also summarized in Table 7.3. 
The intermediate morphology was the most common form found in Opal +/+ and Opal 
+/- MEFs: 67.42% and 66.97% respectively. There was a tendency in wild type cells 
more than in mutant cells to acquire tubular morphology: 27.95%, 12.97% for Opal +/+ 
and Opal +/- MEFs respectively. However Opal +/+ MEFs showed a big variation in the 
percentage of tubular morphology between three different cultures that were studied 
ranging from 57.14% to 12%. A statistically significant difference (T-Test, p<0.05) 
between both lines was found in the category with fragmented mitochondria. 20.06% 
Opal +/- MEFs had mitochondrial particles < 1pm whereas in Opal +/+ MEFs this was
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4.63%. These results suggest that a small population of Opal +/- cells (about 15%) may 
differ from wild type cells in their mitochondrial morphology. More cells with 
fragmented mitochondria would seem to be the effect of a reduction of the pro-fusion 
Opal protein in these cells.
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Fig.7.8 Mitochondrial morphology in Opal +/+ and Opal +/- MEFs. Graph bars show 
the percentage of cells with tubular, intermediate and fragmented mitochondria in both 
genotypes. Data represent mean± SEM of three different cultures for each genotype. 73 
Opal +/+ and 97 Opal +/- cells were scored. (*) P<0.05 versus opal +/+ group.
Mitochondrial morphology [%]
Cells Tubular Intermediate Fragmented
Opal +/+ 
(n=73) 27.95±14.61 67.42±12.28 4.63±2.39
Opal +/- 12.97±3.54 66.97±5.78 20.06±5.05
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Table 7.3 The summary of mitochondrial morphology in Opal +/+ and Opal +/- 
MEFs presented in Fig.7.7. Data represent mean± SEM of three different cultures for 
each genotype. 73 Opal +/+ and 97 Opal +/- cells were scored.
Additionally an alternative approach to the measurement of mitochondrial morphology 
was taken. The mean length of mitochondrial particles in Opal +/+ and Opal +/- MEFs 
was measured (Fig. 7.9). One Opal +/+ MEFs culture had much longer mitochondrial 
particles than any other cultures and on average mitochondria in Opal +/- MEFs were 
shorter than in Opal +/+ MEFs.
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Fig.7.9 Analysis of mitochondrial particles in three Opal +/+ and Opal +/- MEF 
cultures. Mitochondria were stained with Mitotracker Red and mitochondrial particles 
were measured in Opal +/+ and Opal +/- MEFs. The mean length was obtained for three 
Opal +/+ and Opal +/- cultures (black and red circles respectively). Horizontal bars 
show mean± SEM for each genotype (n=3).
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7.4 Opal +/- cell growth
Cells (MEFs) were isolated from 13.5dpc Opal +/- and Opal +/+ mouse embryos 
(Materials and Methods 2.16) (Fig.7.10) and cell growth was assessed by the population 
doubling level measured for 3 weeks (Materials and Methods 2.19). A similar growth 
curve was obtained for Opal +/+ and Opal +/- MEFs, as shown in Fig.7.11. After a fast 
cell growth for about 10 days in both lines there was a significant reduction in their 
proliferation observed over the last week.
OPA1 +/- MEFs OPA1 +/+ MEFs
Fig.7.10 Embryonic fibroblasts 13.5 dpc. Second day after isolation cultured in DMEM 
supplemented with 10%FBS (Materials and Methods 2.16).
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Fig.7.11 Cellular growth of Opal+/~ and Opal +/+ MEFs. Population doubling was 
determined every third day in 3 Opal +/+ and 4 Opal +/- MEFs cultures seeded in 
duplicate. Data represent mean± SEM.
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7.5 Vulnerability to light- and H2 O2 induced oxidative stress
To assess how Opal +/- MEFs are vulnerable to oxidative stress, Opal +/- and control 
Opal +/+ cell cultures were exposed to blue light and hydrogen peroxide, which are 
known to stimulate ROS production and cause apoptosis (Li et al, 2007). The survival of 
cells after treatment was determined in a MTT assay (Materials and Methods 2.22).
7.5.1 Light treatment of Opal +/+ and Opal +/- MEFs.
Cells were treated with blue-filtered light for a maximum of 24 hours and cell viability 
was measured after 12, 18 and 24 hours (Godley et al., 2005). For further details about 
the light treatment protocol see Materials and Methods 2.20. MEFs which were kept in 
the same conditions but not exposed to light were used as controls. Treatment with light 
for 12 hours did not cause any evident cell death in Opal +/- and Opal+/+ MEFs. The 
phototoxic effect was observed after 18 and 24 hours (Fig.7.12), however without any 
significant difference in this effect on mutant versus wild type cells (Fig.7.13).
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Fig.7.12 Viability of Opal +/- and Opal +/+ MESs treated with blue light for the 
time indicated. MEFs o f respective genotype kept in the same conditions but not 
exposed to light were used as controls. The number of viable cells was determined in a 
MTT assay. The values were expressed as percentage of the absorbance value obtained 
for Opal +/+ MEFs kept in darkness (100% value). Data are the means ± SEM of three 
(12 and 24 hours) or two (18 hours) independent experiments. At each time point 6-9
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individual MEFs cultures were analyzed at least in quadruplet. Asterisk denotes values 
significantly different from the respective controls at the same time (P<0.05).
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Fig.7.13 Phototoxicity of blue light on Opal +/- and Opal +/+ MEFs after 18 and 24 
hrs exposition. Data are means ±SEM of two (18 hours) and three (24) experiments and 
are expressed as the fold change in a MTT activity at the indicated time point, calculated 
from the ratio MEFs exposed to light versus MEFs kept in darkness. Student’s t-test 
analysis did not show statistically different effect of light on Opal +/- MEFs when 
compared to Opal +/+ MEFs.
7.5.2 H2O2 induced oxidative stress in Opal +/- and Opal +/+ MEFs
Cells were treated with increasing doses o f H20 2 for 1 hour and 2hours (Frezza at al.,
2006). Doses 0.1-lm M  were tested and the toxic effect was induced with 0.5, 0.8 and 
ImM H20 2 treatment. For further details about the H20 2 treatment protocol see Materials 
and Methods 2.21. MEFs not treated with H20 2.were used as controls. Sensitivity to H20 2 
at the doses 0.5-ImM was similar in Opal +/- and Opal +/+ MEFs. After 2 hours 
treatment the significant reduction (about 60%) was observed in both cell lines (Fig.7.14).
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Fig.7.14 Viability of Opal +/- and Opal +/+ MEFs after 1 hour and 2hours 
treatment with H2O2. Doses 0.5, 0.8 and ImM caused similar reduction in cell viability 
and the obtained results have been averaged. Data are means ± SD of two (1 hour) and 
three (2hours) independent experiments. There was no statistically significant increase in 
vulnerability of Opal +/- MEFs to H2O2- induced death at the doses 0.5-ImM.
7.6 Discussion
Mitochondrial morphology in Opal +/- mice
Opal plays a significant role in mitochondrial inner membrane fusion and maintaining 
mitochondrial morphology. It was expected that mitochondrial morphology might be 
affected in Opal mutant mice due to the reduction of Opal protein in mutant 
mitochondria (see Chapter 6).
Mitochondrial morphology was studied in the retina of 3-month-old mutant mice by qRT- 
PCR analysis of gene expression. The results did not indicate any evident differences in 
the expression of genes that play an important role in mitochondrial membrane 
organization and dynamics of mitochondrial inner membrane (Mfn2, Dnmll, Spg7, Bik, 
Slc25a4, Atp5k). However analysis of mitochondrial morphology in MEFs isolated from 
13.5dpc embryos suggested a higher incidence of fragmented mitochondria in Opal +/- 
MEFs versus Opal +/+ MEFs. This difference applied to approximately 15% of the cell 
population. It is difficult to compare these two experiments. First the change in gene 
expression when measured in the whole retina may be too small to be detected by qRT- 
PCR. It is also possible that mitochondrial fragmentation can be caused solely by Opal
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protein reduction without causing changes in the expression of other genes (see the 
paragraph below) or that genes may be in this case regulated at the posttranslational level 
without affecting their transcription. It would be better to perform both experiments on 
the same samples and if possible combine mitochondrial imaging with the single-cell 
qRT-PCR analysis in cells where an alteration in the mitochondrial network was 
observed.
It was shown on fibroblasts derived from ADOA patients that when cells were grown on 
galactose medium which forced them to use mitochondria for ATP production, in large 
number of cells the mitochondria underwent drastic fragmentation, as opposed to when 
cells were grown on glucose (Zanna et al., 2008). Such an experiment could be also 
performed on Opal +/- MEFs to find out if the change in mitochondrial morphology will 
be enhanced in cells grown on galactose.
Mitochondrial morphology in mouse model of glaucoma. Comparison to Opal 
deficiency-induced mitochondrial fragmentation
Recently significant alterations in Opal (decrease) and Dnml (increase) mRNA 
expression have been found in the optic nerve head of 10 month-old glaucomatous mice 
and these changes were accompanied by substantial optic nerve damage (Won Kyu Ju et 
al., 2008). In glaucomatous mice a bidirectional change was observed: the ‘fission gene- 
DrpV was upregulated whereas the ‘fusion gene-Opal’ was downregulated. Interestingly 
in Opa 1 -ablated MEFs where Opal levels were -30% compared with control cells, other 
mitochondria-shaping proteins such as Drpl, hFisl and Mfn2 were not affected but still 
mitochondrial fragmentation was observed (Cipolat et al., 2004). The results were not 
shown and possibly protein rather than mRNA expression was studied but it seems that 
the reduction in Opal expression alone, without changes in the expression of other genes, 
as reported in glaucomatous mice, was sufficient to induce an imbalance in the 
mitochondrial morphology. These two examples suggest the presence of different 
molecular mechanisms that could lead to mitochondrial fragmentation.
Cell viability and sensitivity to oxidative stress in Opal +/- MEFs
The viability of Opal +/- MEFs was studied by observation of cellular growth and an 
oxidative stress-induced cell death. Cell growth was studied by calculation of population 
doubling level. Survival after blue light and hydrogen peroxide (0.5-ImM) was measured 
in a MTT assay. In neither experiments the differences in Opal +/- MEFs behaviour
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could be detected, when compared to the control Opal +/+ cells. More such research 
evaluating the role of oxidative stress in the Opal mouse model is needed. An increased 
oxidative stress was found to be the hallmark of pathology in the heterozygous 
Drosophila model of ADOA (Tang et al., 2009). On the other hand Frezza et al. (2006) 
showed that the onset of H2 0 2 -induced apoptosis in cells can be delayed by over­
expression of wild-type Opal protein (Introduction 1.2.6). Oxidative stress induced in 
Opal +/- MEFs could be further studied by e.g. the measurement of ROS production and 
counting cells undergoing apoptosis.
Since RGCs in the retina are exposed to light, it would be interesting to study the effect of 
increased exposition to light on visual performance and retinal damage in living Opal +/- 
mutant mice. This would answer the question of whether Opal mutations can make 
RGCs more vulnerable to light-induced apoptosis.
Limitations concerning the use of fibroblasts for the assessment of light and 
hydrogen peroxide toxicity
Opal +/- MEFs did not demonstrate an increased vulnerability to oxidative stress. 
Oxidative stress was induced with blue light and hydrogen peroxide and neither factor 
increased the percentage of the mutant cell death when compared to WT cells. However, 
this finding cannot be directly translated to the vulnerability of RGCs in our mutant mice. 
It is not clear whether RGCs would respond to the oxidative stress similarly to MEFs and 
therefore would not show any increase in sensitivity. Preventing cell death initiated by 
oxidative stress has been shown to be cell-type specific (Jarrett, et al., 2006). MEFs are 
actively dividing cells. By contrast, neurons are long-lived, nonproliferative and 
terminally differentiated postmitotic cells which do not undergo a cell division. Therefore 
in neurons any oxidant- induced damage to macromolecules and organelles will 
accumulate, while in fibroblasts this will be continuously diluted during repetitive cell 
divisions (Terman et al., 2007). It has been also observed that oxidative stress can induce 
replicative senescence (growth arrest) in fibroblasts (Parrinello et al., 2003). This 
mechanism cannot occur in neurons which are already at a nonproliferative stage. 
Furthermore due to their electrical excitability, and structural and synaptic complexity, 
neurons depend on an enhanced metabolic rate with high levels of O2 utilization and ATP 
synthesis. This increases the risk for the generation of elevated levels of ROS. Constant 
exposition of RGC to light may further enhance oxidative stress in these cells and cause 
damage to the mitochondrial genome and cell death, particularly in cells with
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compromised mitochondrial function (Godley et al., 2005, Lascaratos et al., 2007, 
Osborne et al., 2008). Thus, in future experiments it would be desirable to evaluate the 
effect of oxidative stress directly on RGC survival. This would entail the extraction of 
primary RGCs by an immuno-panning method, or assessment on retinal explants. 
However, any such method is inherently artificial due to removing RGCs from their host 
environment and nutritive support, which may play an important role in prevention of cell 
death. Since it has been shown that light is a risk factor and generator of ROS, another 
approach would be to study RGC death in vivo in mice exposed to light.
Concluding remarks
Imaging of mitochondrial morphology has given an indication that a small population of 
cells may be affected by Opal protein reduction. It is too preliminary to say how this 
finding represents biological changes occurring in the retina of mutant mice, although it 
would be very tempting to think that similarly in a subpopulation of retinal ganglion cells 
mitochondrial morphology abnormalities develop which could explain the late onset and 
slow progression of the disease observed in Opal +/- mutant mice. More research is 
needed using sensitive methods to detect probably mild changes. If the defect in 
mitochondrial fusion is the primary cause of RGCs dysfunction, in order to understand 
ADOA disease it would be helpful to reconstruct the course of molecular events taking 
place in RGCs in response to this defect.
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8. DISCUSSION
This work present results from the study of OP A1 -associated disease in a mouse model 
B6;C3-OpalQ285STOP. The main findings and accomplishments are:
• Opal heterozygous mice show ~ 50% reduction of Opal in their mitochondria 
from the retinal tissue
• The reduction of Opal in the mitochondria results in a higher incidence of 
mitochondrial fragmentation, as shown in Opal +/- MEFs and compared to Opal 
+/+ MEFs
• A considerable number of mitochondria in the retina of young mutant mice appear 
to maintain an intact IMM structure
• Despite degenerative changes in the optic nerve in 24 month old mutant mice 
(White et al., 2009) significant RGC loss is not observed
• A new, faster and more reliable genotyping method was designed (Chapter 3)
• RT-PCR analysis of Opal transcripts showed three mRNA isoforms present in the 
retina of mutant and WT mice, with the dominance of mRNA isoform 1 (Davies 
et al., 2007)
• RT-PCR analysis revealed the presence of exon 4 in all mouse Opal isoforms, 
which means that alternative splicing occurs only between exons 4b and 5b, which 
is different from what is found in humans (Chapter 4)
8.1 Opal reduction in mitochondria in heterozygous mice
Western blot analysis confirmed the reduction of Opal protein in mitochondria in 
heterozygous Opal mice. When compared to published studies in vitro where Opal is 
nearly totally silenced by siRNA (Olichon et al., 2003; Griparic et al., 2004), the presence 
of Opal protein produced from one wild type allele, appears, at least to some extent, to 
maintain the Opal function in mitochondria. It can explain why a relatively mild effect of 
OPA1 mutation is observed in tissues obtained from some ADOA patients (Chevrollier et 
al., 2008). In a heterozygous mutant mouse model, which is characterized by slowly 
progressive optic neuropathy (Chapter 1.4.2), the impact of mutation on mitochondria 
was expected to be rather moderate.
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8.2 Mitochondrial network fragmentation in Opal +/- MEFs
Mitochondrial morphology was studied in MEFs isolated from 13.5 dpc embryos. At this 
stage there were no homozygous mutants present, because they died at the earlier stages 
of embryonic development (Davies et al., 2007). Mitochondrial morphology was 
compared between Opal +/- and Opal +/+ MEFs. In Opal +/- MEFs mitochondria were 
more prone to fragmentation, as shown by a higher percentage of cells with an average 
length of mitochondrial particles below 1 pm. Mitochondrial fragmentation has been also 
observed in fibroblasts from human ADOA patients (Olichon et al., 2007b, Zanna et al., 
2008) and in muscle explants from our 3 month old mutant mice. Interestingly, in muscle 
explants most Opal +/- cells displayed punctuated and completely dispersed 
mitochondria. This difference in the degree of mitochondrial fragmentation between 
embryonic fibroblasts and muscle fibroblasts from adult tissue is not understood and 
could be due to the age, the cell type or the culture conditions. Mitochondrial network 
fragmentation was also shown in the Caenorhabditis elegans model, where mutation was 
induced in eat-3 gene, the OPA1 orthologue (Kanazawa, et al., 2008).
Mitochondrial fragmentation is clearly related to the role of Opal in fusion. Decreased 
fusion may shift the balance toward increased mitochondrial fission. However, the 
relationship between the defect in mitochondrial fusion and degeneration of the optic 
nerve is not yet understood. Recently, OPA1 function has been postulated to be important 
for a mitochondrial quality control, which counteracts and protects mitochondria from 
accumulation of the damage. Many specific proteases, chaperones and proteins that 
regulate mitochondrial dynamics and autophagy have been identified in this process 
(Tatsuta et al., 2008). An increased number of autophagic vesicles observed in the RGCs 
of 24 month old Opal mutant mice may suggest “ a state of emergency an 
accumulation of mitochondria with reduced fusion competency and low membrane 
potential, which are targeted for degradation (Twig et al., 2008; White et al., 2009). It is 
also known that RGCs are highly vulnerable to energetic impairment. A defect in energy 
production explains another optic neuropathy: LHON in which mutations in mtDNA 
affect respiratory chain activity (Wallace et al., 1998; Ruiz-Pesini et al., 2007). It is 
possible that the imbalance in the fusion and fission may severely affect mitochondrial 
distribution in axons of the optic nerve and the provision of energy. Interestingly, 
fibroblasts from LHON patients can have a highly interconnected mitochondrial network 
(Chevrollier et al., 2008), whereas this study further supports the view that in ADOA 
mitochondria are likely to become fragmented. So far there has been one study that links
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the loss of mitochondrial fine positioning in the axons of RGCs to the neurodegeneration 
in ADOA (Spinazzi et al., 2008). The study by confocal microscopy showed increased 
mitochondrial fragmentation and uneven distribution in fibroblasts and myotubes from 
patients with deletion in the GTPase domain of OPAl. However, it is worth noticing that 
this mutation is also associated with severe peripheral neuropathy. Mitochondrial fusion 
and fission regulate mitochondrial distribution to the synapse. It was demonstrated that 
the modification in Opal level can influence the maintenance of dendritic spines and 
synapses in hippocampal neurons (Li et al., 2004). Thus, hypothetically, reduced 
mitochondrial fusion may disorganize mitochondrial distribution to RGC dendrites and 
axons and ultimately affect function of the synapses.
8.3 IMM functional and structural integrity in the retina of heterozygous mice
OPAl contributes to the mitochondrial inner membrane (IMM) structure, which implies 
the need for the study of OPAl- associated diseases in the context of structural and 
functional integrity of the IMM (Zanna et al., 2008). The disruption of elaborate IMM 
structure composed of cristae, cristae junctions and domains of interaction with OMM is 
likely to have an impact on respiration and generation of ROS, as well as induction of 
apoptosis by releasing the cytochrome c from the cristae stores. The experiments carried 
out on young Opal +/- mice seem to support the view that IMM structure and energy 
metabolism are normal. Mitochondrial membrane potential across the IMM was 
measured in mouse retinas and brains at 4-5 months and appeared to be stable in the 
mutant mice. Consistent with this an increased Opal proteolysis in the IMM was not 
observed. Furthermore qRT-PCR assessment of the expression of genes involved in 
mitochondrial membrane dynamics in the retina did not find any significant differences in 
the Opal +/- mice, compared to the control group. Overall in the mutant mice by the age 
of 5 months most mitochondria are able to cope with the mutation, such that they 
maintain functional and structural integrity of the IMM. It is important to note that 
whereas these experiments were performed on mitochondrial population from the whole 
retina, EM analysis of the optic nerve revealed some mitochondrial structural 
abnormalities in two Opal mouse models (Alavi et al., 2007; White et al., 2009; 
Introduction 1.4.2; 1.4.3). The advantage of EM is that it enables the detection of changes 
at the level of single mitochondrion. Nevertheless, this may further indicate that 
mitochondria in the optic nerve are particularly vulnerable in OPAl- associated disease. 
In our Opal +/- mice disorganized cristae was observed in older animals at 24 months,
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which indicates the age-related development of pathological changes. Interestingly, an 
increase in the number of opaque mitochondria was also seen by EM in the optic nerve of 
mutant mice at 6 and 24 months and it was postulated to represent an increase in the 
density of cristae in order to fulfill the energy requirements of the axon. In fact, these 
results seem to suggest that in the RGC axons mitochondrial energy metabolism is likely 
to be affected and that mitochondria develop a compensatory strategy to ensure survival 
of the cells.
8.4 Lack of evidence on RGC loss in 24 month old heterozygous mice
Signs of optic nerve degeneration were observed by EM in both mouse models. 
Surprisingly, RGC loss or even a tendency in decreasing the number of RGCs on H&E 
stained retinal sections was not observed in mutant mice at 24 months. This may suggest 
that the optic nerve is the primary target of the disease in the mutant mice. However, 
there is also possibility that the RGC count was not accurate enough. As described in 
Discussion to Chapter 5, RGC layer is comprised of approximately equal numbers of 
RGCs and displaced amacrine cells, which could make the observation of a decrease in 
the number of only RGCs difficult to detect on retinal sections. To circumvent this 
limitation the different approach could be used e.g. Alavi et al., 2007 studied RGC loss in 
another Opal +/- model on the whole mount retinal preparations with retrograde labelled 
RGCs and was able to show a time-dependent RGC loss from the retina.
8.5 Conclusions (Fig.8.1)
Taking all the evidence we have from the B6;C3-Op«7L122P mouse, it is possible to 
postulate some mechanisms and hypotheses regarding the pathophysiology of the ADOA 
phenotype that we are attempting to model.
Heterozygous Opal mice develop signs of visual dysfunction which first became 
apparent at the age of 12 months. A significant degenerative process seems to proceed in 
the RGC axons affecting nerve myelin, yet, so far, without any evidence for the loss of 
RGC bodies in the retina (Fig.8.1-1). Studying the magnitude of mitochondrial 
impairment showed partial fragmentation of the mitochondrial network in Opal +/- 
MEFs, which suggests a defect in mitochondrial fusion (Fig.8.1-2). Many studies have 
indicated that mitochondria with this defect have aberrant ultrastructure, distribution and 
electron transport chain activity (Chen et al., 2007) and that their accumulation will have
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a severe impact on the cell maintenance and stress response. However, study in vitro of 
Opal +/- MEFs did not find any apparent weakness in these cells: their proliferative life 
span, and susceptibility to oxidative stress were similar to MEFs derived from WT mouse 
embryos. The defect in fusion must be subtle and does not culminate in cellular 
dysfunction of MEFs. So what could be said from this about RGCs? (Fig.8.1-3). In 
contrast to MEFs, RGCs are postmitotic neuronal cells, cannot divide and their 
mitochondrial network looks different, the cells have shorter and less connected 
mitochondria. Also, it has been recently postulated that proteins related to mitochondrial 
fusion/fission play a direct, more active role in controlling cell survival in neurons and 
thus neurons are more sensitive to the change in their expression (Uo et al., 2009). 
Therefore the comparison of MEFs and RGCs in their response to Opal deficiency 
cannot be straightforward.
Next, in the Opal +/- retina there was no indication of any deficiency in the energy 
metabolism in young animals (Fig.8.1-4). This was mostly concluded from the 
observations that mitochondria maintained normal membrane potential and that there was 
normal expression of a few genes associated with mitochondrial activity and IMM 
ultrastructure. These data, however accurate they are in relation to the whole retina, they 
may be misleading or not too relevant when trying to link them to the pathological 
process occurring in the Opal +/- mice (Fig.8.1-5). It may have been using too “bulky“ 
an approach for studying fine mitochondrial aberrations that do occur specifically in the 
optic nerve as evidenced recently by EM. EM showed distinct morphologic remodeling of 
mitochondria and increased autophagy, which are likely to accompany deregulation of 
mitochondrial activity. Another factor that could significantly influence the results 
obtained on the retina is the age of animals studied. Due to the late onset of the disease, at 
the preclinical stage (3-5 month old animals) there will be less defective mitochondria 
and more difficulties to spot them and estimate the magnitude of their dysfunction.
Finally, how does the defect in mitochondrial fusion affect RGC function? At present 
there is a view which links this to the disruption of specific distribution of mitochondria 
that occurs in the RGC axons. It may be that mitochondria do not go where their presence 
is essential. We may see degeneration of the axons which are overloaded with abnormal 
mitochondria and an increase in the autophagic process. However, sadly we do not know 
what it all means to the cell. The cellular language has so far been untouched. There has
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recently been one significant discovery which showed that cone degeneration in retinitis 
pigmentosa could be due to the cone starvation induced through the changes in the 
insulin/mTOR pathway (Punzo et al., 2009). Similar molecular in-sight in ADOA RGCs 
is awaited with interest (see also 8.6).
8.6 Future research and avenues for therapy
Future study on ADOA carried out on this mouse model could focus on detailed 
understanding of Opal- mediated mitochondrial quality control in RGCs, which relates 
mitochondrial fusion to autophagy and how this process is integrated into cellular 
signaling pathways that govern RGC functions and apoptosis. Furthermore more 
experiments to measure mitochondrial morphology and function in RGCs and the optic 
nerve need to be undertaken. The experiments such as: the measurement of activity of 
respiratory chain complexes, membrane potential, ATP synthesis and mitochondrial 
distribution could be performed systematically over longer period of time on younger and 
aging animals.
In relation to RGC specific vulnerability in ADOA it is important to broaden our 
understanding of biological differences between different tissues and the possible specific 
thresholds that set the maximal limit of tissue adaptation to stress and instability. In this 
work for example the dominance of Opal isoform 1 transcript in the retina was found 
(another study showed the dominance of isoform 1 protein in neuronal tissues, including 
the retina (Akepati et al., 2008)). However, it is not known what it means in the context of 
mitochondrial function in neurons. Tissue specificity also requires more study that takes 
into account not only the intrinsic properties of the tissue but also its localization, external 
surrounding and environmental factors, such as light, with regard to RGCs. Since it has 
been identified that OPAl mutations are also associated with multi-systemic 
mitochondrial disorders, the challenge now is to design treatments that will be beneficial 
for all patients with OPAl mutation. Would it be possible to design one treatment that 
will be universal for all patients with different ADOA phenotypes? The pharmacological 
strategies that would enhance energetic metabolism or prevent apoptosis were proposed 
to have potentially therapeutic effect on optic neuropathies (Amati-Bonneau et al., 2009). 
Gene therapy aiming at increasing OPAl expression in the eye could be beneficial for 
patients with haploinsufficiency. It is not entirely clear yet whether the primary site of 
injury in ADOA is the RGC axon or body and this information would be useful in finding 
an effective neuroprotection (Levin, 2007).
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Fig. 8.1 The summary of the results on ADOA mouse model.
In heterozygous mice the defect in mitochondrial fusion can be 
responsible for mild optic degeneration and visual dysfunction. No RGCs 
loss in old animals suggests that the primary site of pathology is in RGC 
axons.
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APPENDICES
APPENDIX 1
Digestion Solution Master Mix (DNA extraction. Chapter 2.2)
Nuclei Lysis Solution 200pl
0.5M EDTA (pH 8.0) 50pl
Proteinase K, 20mg/ml 20pl
RNase A Solution 5pi
Total Volume 275pl/sample
TBE buffer 5x (Agarose gel electrophoresis. Chanter 2.4f
Tris base 54g
Boric acid 27.5g
0.5M EDTA (pH 8.0) 20ml
Make up to 1L
1.2% Denaturing (formaldehyde) agarose gel (Chapter 2.5)
150ml:
Agarose 1.8g
1 Ox MESA buffer 15ml
Add RNase-free H2O to 150ml
Heat the mixture to melt agarose, cool to 65°C
Add 2.7ml of 37% formaldehyde
and 1.5 pi of lOmg/ml ethidium bromide stock solution
Prior to running the gel, equilibrate in lx FA running buffer for at least 30min
MESA buffer lOx (Chapter 2.5)
200mM MOPS (41.8g in 700ml DEPC treated H2O ) adjust to pH 7.0 with 2NaOH
20ml DEPC treated 1M sodium acetate (1M sodium acetate- 13.6g in 100ml)
20ml of 0.5M EDTA (pH 8.0)
Adjust the volume to 1L with DEPC treated H2O
Formaldehyde agarose (FA) running buffer (Chapter 2.5)
100ml lOx MESA buffer 
20ml 37% formaldehyde 
880 ml RNase-free H2O
TE buffer (Chanter 2.6)
lOmM Tris-HCl 
ImM EDTA, pH7.5
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PBS buffer
NaCl 8g
KC1 0.2g
Na2HP04 14.4g
KH2PO4 2.7g
Dissolve in 800ml H20 . Adjust to pH 7.4 with HC1 
Add H20  to 1 liter.
Sample Loading Buffer 2x (western blotting. Chapter 2.12)
4% SDS 4ml of 10% SDS
20% glycerol 2ml
120mM Tris 2.4ml 0.5M Tris pH 6.8
Water 1.6ml
Bromophenol blue 0.01%
Resolvine eel (8%) (Western blottine. Chapter 2.12)
Acrylamide (30%) 2.7ml
MilliQ 4.6ml
1.5M Tris pH 8.8 2.5ml
10% SDS 0.1ml
10% APS 100 pi
TEMED 20 pi
Stackine eel (5%) (Western blottine. Chapter 2.12)
Acrylamide (30%) 1.67ml
MilliQ 5.83ml
0.5M Tris pH 6. 2.5ml
10% SDS 0.1ml
10% APS 50pl
TEMED lOpl
SF10PF medium (lieht treatment protocol. Chapter 2.19)
SOml:
lOx SF10PF 5 ml
MilliQ 42.5ml
20mM HEPES 1ml
Sodium bicarbonate 60mg
FBS 1ml
Antibiotic-Antimycotic lOOx 0.5ml
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APPENDIX 2
I. Concentration of mitochondrial proteins isolated from the retina (with proximal 
part of optic nerve attached) in Opal +/+ and Opal +/- animals.
Each sample is pooled from 3 animals. Each reading is a mean of three readings.
Total mitochondrial protein concentration from retina [mg/ml]
sample Opal +/+ m eani SD Opal +/- mean± SD
1. 11.95± 0.86 10.50± 0.07
2. l l . l l i  1.03 11.87± 0.79
3. 12.06± 0.81 11.91^0.84
II. Concentration of mitochondrial proteins from brain in three Opal +/+ and Opal 
+/- animals. Each reading is a mean of three readings.
Total mitochondrial protein concentration from brain [mg/ml]
Sample Opal +/+ mean± SD Opal +/- mean ± SD
1. 10.35± 0.11 9.30± 0.11
2. 13.00± 0.08 10.94± 0.18
3. 8.00± 0.14 9.90± 0.43
III. RNA concentration obtained from retina of WT Opal +/+ and mutant Opal +/■ 
mice (Opal +/- samples are labelled red).
RNA QUANTIFICATION [pg/ml]
animal
RNA
1
51.95
2
48.55
3
23.85
4
47.65
5
86.05
6
59.85
7
73.95
8
76.65
9
78.65
10
65.55
animal
RNA
11
80.95
12
87.75
13
59.75
14
91.65
15
72.55
16
67.15
17
72.05
18
52.95
19
59.55
20
45.05
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